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Abstract
A Preliminary Study of Specific Symptoms Experienced by Individuals with Bipolar
Disorder
Gail Reichman Mancini
PsyD. July 2005
Philadelphia College of Osteopathic Medicine
Barbara Golden, Dissertation Advisor
The present study attempted to empirically identify symptoms of bipolar disorder to
define a more accurate clinical description. A group of 30 individuals with a formal
diagnosis of bipolar disorder, who had joined a support group as outpatients, a
comparison group of 30 individuals with unipolar depression from an outpatient support
group, and 30 nonpatient adults were administered identical measures of symptoms.
Results suggested that individuals with bipolar disorder endorsed symptoms correlated
with paranoia to a greater degree than individuals with unipolar disorder or nonpatient
adults. In addition, symptoms of hostility, interpersonal sensitivity, depression, anxiety,
global severity and psychoticism, as defined by the SCL-90-R, were prominent features
to a significant degree when compared with nonpatient adults. The implications and
limitations of the findings are discussed.
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CHAPTER 1
Introduction
Statement of the Problem
Bipolar disorder is a major mental disorder characterized by a variety of
symptoms including severe mood changes. The essential feature of bipolar disorder is a
clinical course that is characterized by the occurrence of manic or mixed episodes, with a
shift of polarity from normal functioning. Manic episodes can be so severe that they
cause significant impairment in social or occupational functioning, may require
hospitalization and include psychotic features. Statistics indicate that between fifteen to
nineteen percent of patients with bipolar disorder commit suicide, a considerably serious
mortality figure (Goodwin & Jamison, 1990, Simpson & Jamison, 1999). The
consideration of a psychiatric illness with classic presentations such as bipolar disorder is
currently limited to therapeutic advances in treatment of the behavioral and emotional
manifestation of the disorder. There is a possibility that specific symptoms exist but are
not clearly defined or empirically validated. Rather than focusing solely on acute
behavioral and emotional manifestations, identification may provide opportunities to
minimize the destructive nature of the course of this illness through appropriate and
effective interventions. Such an investigation appears to be a valid focus of
consideration. The identification of a cluster of distinguishing symptoms could assist
mental health professionals in designing treatments specifically conceptualized to address
the more encompassing needs of individuals with bipolar disorder.

Purpose of the Study
The intent of this study was to begin to identify the salient and common
symptoms of individuals with bipolar disorder. The main purpose of this study was to
provide clarification of symptomatology, and thereby enhance understanding of this
disorder. This effort was designed to identify those symptoms for the ultimate purpose of
providing a paradigm from which those individuals, their families, and mental health
professionals can work. Provision of guidelines stemming from such research can serve
to offer appropriate support and plan proactive treatment strategies. A study which
focuses on identifying symptoms and symptom clusters that unite and distinguish bipolar
disorder can also serve to bring attention to the patient’s discomfort, one of the most
important aspects of any mental disorder. This focus may help to circumvent the pitfalls
to which identified individuals with serious mental health disorders succumb.

Rationale
Just as an elevated temperature in a youngster can alert a physician to numerous
potential illnesses, particularly when clustered with additional abnormal physical
complaints, significant emotional or behavioral symptoms may be only one part of a
variety of potential syndromes. Viewing symptoms in a vacuum with only palliative
treatment can reduce distressing symptoms temporarily, but may miss the larger and
more serious illness. Additionally, treating any symptom presentation in isolation, and
ignoring other indicators because they have not been identified as such, may in fact
worsen the outcome for an individual both physically and emotionally.

Description
Bipolar disorder can be currently distinguished as either Bipolar I or Bipolar
II. A current consensus regarding the distinguishing characteristics of bipolar
disorder has been agreed upon and published in the American Psychiatric Association:
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision
(2000). This publication is different than prior texts because diagnostic categories now
point toward the longitudinal course of the illness rather than the presentation of
behavioral manifestations.
The essential feature of Bipolar I is a clinical course that is characterized by the
occurrence of one or more manic or mixed episodes, with a shift of polarity from normal
functioning. A manic episode is diagnosed if a distinct period is experienced, during
which there is an abnormally and persistently elevated, expansive or irritable mood for at
least one week. Cassidy, Forest, Murry & Carroll (1998) reported that five
independent factors can be manifested in mania. Those are a dysphoric mood,
psychomotor pressure, psychosis, increased hedonic function, and irritable aggression.
Additional symptoms cited in the DSM-IV-TR (2000) text revision can include inflated
self-esteem, grandiosity, a decreased involvement in goal directed activities or
psychomotor agitation, and excessive involvement in pleasurable activities despite a high
potential for painful consequences. The episode must be sufficiently severe to cause
significant impairment in social or occupational functioning or require hospitalization, or
include psychotic features. A mixed episode includes the occurrence of daily manic and
major depressive features.
Bipolar II disorder includes major depressive and hypomanic episodes. A

hypomanic episode is considered a distinct period of an abnormally and persistently
elevated mood that is nondelusional or hallucinatory. Diagnosis requires a shift in
polarity. In contrast to mania, hypomania is not severe enough to cause marked
impairment or hospitalization. The mood can be described as euphoric.

Related Research
Etiology
The etiology of bipolar disorders remain the subject of research with continued
interest. Genetic factors have long been implicated in the etiology of bipolar disorder,
however, research has provided few answers regarding the mode of inheritance. Smith &
Weissman (1992) speculate that many genes with small effects, as well as environmental
factors, may be involved in the manifestation of this disorder. Prathikanti & McMahon
(2001) cite the complexity of bipolar affective disorder as the impediment to interpreting
genome-wide scans when searching for disease etiology. They report that few findings
have reached the "suggestive" threshold, and fewer have reached a significant threshold.
Potash et al. (2001) state that studies have provided some evidence for
overlapping genetic susceptibility in their research on the familial aggregation of
psychotic affective disorders. They found that symptoms of hallucinations and delusions
do show a familial aggregation in bipolar disorder pedigrees, lending support to the
hypothesis that a vulnerability to this disorder may be genetic in origin. Dr. Arlen Price
(1993), Director of the Genetics Program in the Department of Psychiatry at the
University of Pennsylvania, views the research as indicating that mental illness comprises
genetically distinct but clinically overlapping disorders. Following his theoretical view,

Bipolar II may not be a milder form of Bipolar I, but rather an entirely different disorder
of the mood disorder spectrum.
Studies indicate that patterns and rates of bipolar disorder are significantly similar
in diverse countries and cultures worldwide, according to Weissman, et al. (1996). The
similarity of presentation of bipolar disorder between cultures appears to support a
theoretical position of genotypy. Genetic mechanisms may be responsible for
determining the distinctive forms of mental illness, however these disorders are difficult
to trace because of their complexity. Thus, researchers have uncovered many markers
which were believed to have a linkage with bipolar disorder, but none have proven to be
reliably linked upon replication of studies. Specific candidate gene locations have been
proposed, disconfirmed or withdrawn. For example, the catechol O-methyltransferase,
an enzyme that inactivates catecholamines, was studied using biochemical methods by
Guitierrez, et al. (1997) in 88 bipolar subjects and 113 healthy comparison subjects. No
allelic or genotypic associations were observed. No single mechanism has been found to
form the basis of bipolar disorder. Investigations continue to proceed searching for a
link and some trait dependent variables appear to be promising.
The concordance rate among identical twins for bipolar disorder is 62%, with the
remaining 38% not having this disorder, according to Price (1993). Although considered
familial, bipolar disorder is not necessarily inherited. The heuristic question of why some
individuals do experience severe pathology while others apparently do not has merit.
The questions of which mechanisms mediate the outcome of severe psychopathology is
the underlying motivation of research, attempting to prevent or minimize the occurrence
of devastating mental illnesses.

Phenomenology
It is widely believed that bipolar disorder generally manifests during the second
decade of life: however, age of onset is currently being disputed. Geller & Luby (1997)
have found that prepubertal bipolar disorder can manifest itself, although not necessarily
in the same form as in the adult presentation. The developmental characteristics which
are typically associated with different age groups apply to childhood and adolescent
bipolar disorder, as well. Pathological grandiosity and involvement in pleasurable
activities specifically present differently than the adult version as a function of age.
Geller & DelBello (2003) have investigated the occurrence of bipolar disorder
among even younger children and propose that the manifestations of childhood and
adolescent mania and hypomania differ from those in adulthood in several ways as a
function of age and developmental level. In their conceptualization based on the work of
Biederman, Faraone, Hatch, Mennin, Taylor & George (1997), the juvenile presentation
typically includes daily rapid cycling, comorbid attention-deficit/ hyperactivity, and
conduct disorder. Prepubertal bipolar disorder, beginning at age ten, appears to differ
from the adolescent presentation with such symptoms as dysphoric mania, irritability, or
aggressiveness, without definitive cyclical episodes followed by moods that are more
normal.
Geller & Luby (1997) also speculate that treatment of these children is provided
to the most severely disturbed cases only. They believe this occurs for several reasons.
An overly accepting parental attitude of developmental phases in childhood may preclude
referral for diagnosis or treatment. Parents with bipolar disorder have a higher incidence
of children with affective disorders may be undiagnosed themselves, and not alert to

symptoms in others.
Strober, Hanna, &&McCracken (1989) found considerable overlap among the
childhood externalizing disorders and mania. For example, adolescent mania is often
misdiagnosed as Attention Deficit Hyperactivity Disorder or Conduct Disorder. That
adolescents display less psychosis than adults is consistent with one hypothesis;
differences between adolescent and adult mania may be due to adults having a more
mature or advanced form of illness, and are more likely to become psychotic because
they have been ill longer.
According to researchers such as Cannon, et al. (1977), impaired social
functioning is also seen in the premorbid state. Additionally, these researchers have
found that poor premorbid social adjustment is one manifestation of vulnerability to adult
psychotic disorders, although more so with schizophrenia than with bipolar disorder.
Consistent with earlier research describing social functioning, Geller & DelBello
(2003) described adolescents with subsyndromal bipolar disorder as exhibiting
impairment in social, family and school functioning. They report that pathogenic
processes may be neurodevelopmental in origin. Leading to psychosis in adulthood, these
processes can predispose a person to attentional difficulties, distorted perceptions,
unusual thought processes and decreased empathic ability in the premorbid phase.
With regard to epidemiology, Carlson & Kashani (1988) collected data which
suggest that the prevalence of adolescent bipolar disorder is at least that of the adult
population. McElroy, Strakowski, West, Keck and McConville (1997) concluded that
adolescents are more likely to present with depression. This may be due to maturational
factors which influence the expression of bipolar disorder. The initial presentation of

depression may be because of the degree of cortical synaptic density reduction, or
synaptic pruning that occurs during adolescence. Classic mania may be dependent on the
degree of central nervous system development required for its expression.
Roberts, Parker, Woogh, Cripps & Froese (2000) commented that a lack of
consensus on the diagnostic criteria and prevalence of bipolar disorder in childhood and
adolescence continues. They noted that bipolar disorder consistent with the adult
phenotype is almost never seen in children or adolescents, and that diagnosis of
childhood mania is controversial. They note that younger individuals do not typically
demonstrate episodic mood cycles. They generally demonstrate a chronic presentation of
rapid cycling, aggression, severe affective storms and impairment in psychosocial
functioning, sometimes comorbid with Attention Deficit Hyperactivity Disorder and
Conduct Disorder. To test their position, these researchers collected information using a
database of the records of 1,697 children assessed and treated at the Child and Family
Unit at Kingston General Hospital, Ontario, Canada. They compared those files with a
psychiatric case register of adults receiving psychiatric services via the Kingston
Psychiatric Record Linkage System. Their results indicated that none of the children
diagnosed with Attention Deficit Hyperactivity Disorder were diagnosed with bipolar
disorder as adults. Surprisingly, three of the non-Attention Deficit Hyperactivity
Disordered individuals did receive a diagnosis of bipolar disorder. They concluded that
it is preferable to err on the side of caution. Adherence to conservative diagnostic criteria
for children and adolescents may be considered a more prudent course of action.
The evidence to date appears to raise more questions than definitive answers
about the course of bipolar disorder. The presentation of bipolar disorder and its

diagnosis is controversial, except in the most serious or blatant examples of
psychopathology. The task of creating a diagnostic tool which fully reflects the internal
symptom clusters and their severity has not been developed to date. Clinicians and
researchers cannot consistently or reliably identify bipolar disorder from its comorbid
presentations. This dearth of knowledge underscores the need for more detailed and
accurate information about this disorder, with a focus of providing treatment, which is
empirically valid and efficacious.

Stress Effects
Of relevance to this discourse is the kindling paradigm, originally posited by Emil
Kraepelin (1962), which describes an analogy between the episodic natures of mood
disorders and the phenomena of kindling, or sensitization. Initial episodes in Bipolar I
patients are significantly associated with the occurrence of major negative life events. As
described in the kindling model of limbic hypersensitivity, key aspects of bipolar disorder
include the onset of early episodes preceded by major stress, whereas later
episodes seem to occur without provocation. Likewise, the untreated mood episodes
worsen over time, and the intervals between episodes become shorter and shorter.
Post (1993) more recently speculated that recurrent episodes might contribute to
persistent brain changes, in a kindling-behavioral sensitization model of recurrent
affective disorders. He notes that the first episode of bipolar disorder is more likely to be
associated with significant psychosocial stressors, while succeeding episodes are more
likely to occur in the absence of a significant life event. He suggested that an analogous
model exists between this phenomena and documented animal research of kindling-

behavioral sensitization. Evidence of neurophysiological change, specifically the
progressive vulnerability to seizures, may be similar to the evolving course of bipolar
disorder.
MacQueen, Young, Robb, Marriott, Cooke & Joffe (2000) extended the kindling
theory. They found that the number of depressions becomes a significantly greater
determinant of reduced functioning than the number of manias experienced. In addition,
the episode, number and outcome are not linear in relationship. The first several episodes
of depression appear to be the determining factor contributing to functional decline.
Most recently, consistent with this finding is the comprehensive review of
research presented by McEwen (2003) at The University of Pennsylvania, Psychiatry
Grand Rounds, titled “ Does stress damage the mind? Implications for long-term anxiety
related disorders." McEwen described the pathophysiology of depression and resultant
stress on the brain within the amygdala and hippocampus specifically. A review of
research (Gould, McEwen, Tanapat, Galea & Fuchs, 1997; Mondlewicz & Klotz, 1981,
Sheline, 2000) provided the basis for his emphasis that chronic depression or successive
depressive episodes result in reduced hippocampal volume and cognitive impairment, as
well as hypertrophy of the amygdala. He likened the damage of chronic stress to ischemia
within the cardiovascular system. Additionally, McEwen described the process of brain
neurogenesis, whereby cells regenerate within the dendate gyrus of mammals.
Neurogenesis appears to be regulated and compromised by stressful experiences.
McEwen noted that certain variables support neurogenesis, such as the hormone estrogen,
the neurotransmitter serotonin, use of antidepressants, exercises, and trace conditioning.
Concerning stress reactivity, Hammen & Gitlin (1997) suggested that stressors

precipitate episodes of bipolar illness, particularly in patients who have experienced prior
episodes. In their study, 52 patients with Bipolar I were followed longitudinally. Using a
structured clinical interview conducted at three-month intervals during a two-year study,
they evaluated the objective stressfulness of events. Using a five point scale of severity,
it was found that patients who had episodes of illness during follow-up had experienced
significantly more severe stressors than those without.
These findings underscore the significant role that stress plays in contributing to
this disorder. Stressors may precipitate the initial episodes as well as contribute to
relapses. Although considered familial, bipolar disorder is not necessarily inherited.
This dichotomous phenomenon may be mediated by environment, both in utero or after
birth, throughout childhood or during adolescence. Prima facie consideration leads to the
proposition that contributing factors of bipolar disorders, if not exclusively genetic, must
therefore include physical, social or psychological variables that may significantly impact
on an individual. For example, just as an extremely hostile or threatening environment
can create distress and secondary disorders which are sequelae to that distress, several
investigators propose that environment may contribute to more severe forms of
psychopathology. Bipolar disorder, via pathophysiological determinants as well as a
wide array of external and internal variables, may also follow this pattern (Mazure,
1995).
A clear example of how environment can correlate with bipolar disorder was
demonstrated in a study conducted by Brown, van Os, Driessens, Hoek, & Susser (2000).
One result of the Dutch Hunger Winter of 1944-1945 was prenatal famine. If famine
occurred in middle to late gestation periods, an association resulted between adults with

unipolar and bipolar disorders requiring hospitalization. Studying birth cohorts
of individuals requiring hospitalization for major affective illness, siblings who did not
suffer famine in utero during the middle to late gestation periods were not affected. The
underlying mechanisms responsible for this outcome are not clearly delineated as
nutritional deficiency alone, but may actually be any one or a combination of factors
which correlate with famine.
Current Treatments
Pharmacological Treatment Challenges and Paradigms
Lithium treatment has provided a long track record of clear advantage, according
to researchers (Shou,1997; Rosenthal, 2001). For example, lithium's effect on preventing
suicide is well established. It does not have a specific central nervous system
depressant effect. However, lithium poses a neurotoxic potential, with a very small
margin of safety. Lithium has a low therapeutic index, and such factors as a loss of fluids
due to excessive sweating or by diuretics can cause plasma levels to exceed the safe
range (Goldstein, 1998). Careful blood level monitoring is required to avoid a toxic
accumulation of lithium. Lithium may not be sufficient in ameliorating symptoms, or be
an optimum choice for some individuals in whom it is contraindicated. Goldberg (2003),
in his review of the impact of different medications on cognition, states that lithium
causes short and long term verbal memory deficits and executive dysfunction.
Pharmacological treatment options have expanded in recent decades effectively
treating what was an intractable illness. Anticonvulsants and newer antipsychotic
medications have most recently assumed a role in treatment. The initial studies of
anticonvulsants focused on lithium-resistant patients, especially rapid-cyclers, and mixed

states of concurrent substance abuse. Within the new armamentarium of this class of
drugs, the advantages of mood stabilization occur along with unwelcome cognitive side
effects.
In refractory bipolar disorder, new treatment options may include three or more
medications provided in combination. The use of combination medications has achieved
success in otherwise refractory bipolar disorder. This protocol may lend support to the
theory that bipolar disorder, in its different manifestations may actually be several
different disorders with similar characteristics. However, Calabrese (2003) posits another
theory of why multiple medications are recommended. His theory supports the use of
combination pharmacological treatments because there are multiple fundamental
components underlying this disorder, such as; depression, anxiety, irritability, psychosis
or hyperactivity. Bipolar disorder can present as a multi-faceted illness with several
discrete manifestations. If addressing the specific symptoms of this disorder is a
necessary focus of treatment, then identifying those symptoms in an empirical manner
would appear to be a priority.

Psychotherapeutic Treatment Challenges and Paradigms
There are individuals with bipolar disorder who do not respond well to even the
most aggressive pharmacological interventions. Others may be unable to cope with the
recurrent nature of this disorder, or the narcissistic injury of having a serious mental
disorder. Although pharmacology is the bedrock of treatment, adjunctive psychotherapy
may be necessary and invaluable. Medication does not teach an individual how to
develop adaptive strategies for coping, or cognitive strategies to compensate for deficits.

Medication alone does not offer the psychoeducation necessary to understand and
manage the associated problems of bipolar disorder. For these reasons, a number of
psychotherapeutic approaches and foci have been developed.
Behavioral treatments may include interventions designed to circumvent
controllable aspects of bipolar disorder, such as sleep dysregulation and insufficient
exposure to broad spectrum light. Wehr (1993) has investigated causes of depression and
mania and found that depression may be triggered by insufficient broad spectrum light.
He theorizes that this phenomenon is applicable to bipolar depression. Animal research
has also shown that serotonergic systems regulate numerous physiologically based
behaviors such as appetite, circadian rhythm, and carbohydrate craving. Research has
also shown that depression can be triggered by excessive sleep, and, conversely, mania
can be triggered by sleep deprivation (Wehr, 1989). Therefore, individuals who
experience vegetative symptoms such as excessive sleep may exacerbate their depression.
While sleep provides mental and physical restoration and may interrupt a manic episode,
excessive sleep may contribute to a prolonged depression. The imbalance of bipolar
disorder may extend to imbalances in many physiological and behavioral systems. A
remedy for those imbalances may best be served through interventions, which are
cognitive and behavioral in orientation.
Psychotherapy as an adjunctive treatment offers patients a substantial benefit. For
example, research on the effectiveness of lithium itself, or in conjunction with other
pharmacological agents, has often been precluded from completion due to the patient's
interruption of lithium prophylaxis on their own initiative. Guscott & Taylor (1994)
suggested that diminished or poor compliance with lithium therapy may account for

discrepancies in determinations of lithium efficacy, noting that a majority of
patients fall in the category of noncompliance. These researchers additionally postulate
that noncompliance may be another manifestation of manic decompensation.
Information, support and supervision may be inadequate in counteracting the
tendency of bipolar patients to discontinue their medications, according to Maj, Pirozzi,
Magliano and Bartoli (1998). Salzman (1998) reports that convincing patients of the
necessity of medication to stabilize this mood disorder can be formidable.
There are several challenges to adjunctive psychotherapy with bipolar disorder,
which may not be unique, but do pose a particular threat to the outcome of treatment.
Establishing a working alliance, one of the key components of psychotherapy
which is generally agreed as necessary for a successful outcome, can be a difficult task
with a patient with bipolar disorder. Gaston's (1990) multidimensional definition of the
construct of the alliance includes: (a) the patient's capacity to work intentionally in
therapy, (b) the affective bond with the therapist, (c) understanding and empathy by the
therapist, and (d) the agreement goals and tasks of therapy. The working alliance is an
ongoing interpersonal process, which appears to be a robust predictor of therapy
outcome. The working alliance is mediated by each participant’s history, and his or her
degree of trust and the collaboration developed between them. Salzman (1998) describes
the difficulty presented when attempting to build an alliance with a bipolar patient during
the manic phase in particular, when denial of illness in a patient can be greatest. During
the manic phase patients frequently deny that they are ill, and possibly welcome
symptoms. This early impediment to treatment can abort psychotherapy.
The management of bipolar disorder includes patient awareness of prodromal

symptoms, when possible. Lam & Wong (1997) investigated prodromal symptoms and
reported that approximately one quarter of patients in a cross sectional study they
conducted could not detect early warning signs of depression. Most subjects found it
easier to detect the early prodromal signs of mania. This ability to detect early
warning signs and employ successful coping strategies contributed significantly to the
level of social functioning. Level of insight appeared to mediate incorporating
spontaneous strategies. These authors suggested that finding ways of educating patients
in self-monitoring moods, promoting insight, and incorporating good strategies was an
area worthy of exploration.
The depression experienced as part of this disorder can include the risk of suicide
to a greater degree that most other psychiatric populations ( Lam, Jones, Hayward, &
Bright, 1999). Statistics indicate that between fifteen to nineteen percent of patients with
bipolar disorder commit suicide, a considerably serious mortality figure (Goodwin &
Jamison, 1990, Simpson & Jamison, 1999). These researchers found that the suicide
attempts may occur even more frequently, with estimates as high as fifty-six percent.
Consideration of this potential risk to the individual highlights the need for
comprehensive and efficacious treatment of this disorder, to alleviate
symptomatology and help prevent this most serious outcome. Shifting and extreme
moods additionally pose a threat. A psychotherapist can offer support during this
turbulence, and provide a stable reference for patients during these affective shifts.
Judith Beck (1993) has presented her conceptualization of cognitive behavioral
therapy as a necessary adjunctive treatment for patients with bipolar disorder. Therapy
helps in many ways. Because medication compliance is a central issue for bipolar

patients, goals include increasing medication compliance. Patients are educated about
the illness itself and the medications prescribed. Therapy also focuses on solving
practical problems, identifying and responding to dysfunctional thoughts, reducing
stressors that can exacerbate mood or trigger cycling, and learning strategies to manage
the disorder. Due to the high risk of suicide, therapists respond to hopelessness and
suicidal ideation, and make suggestions regarding coping strategies such as increasing
activity level and assigning graded tasks. Solving problems related to this illness include
education about monitoring early warning signs, helping patients to regularize sleep and
eating, activity levels as well as coping with emotional mood swings and their
triggers.
An International Conference in 1999 was conducted by Aaron Beck concerning
the cognitive therapy of bipolar disorder. Beck presented a comprehensive approach via
a cognitive theory of bipolar disorder, which addressed many of the tasks of therapy in
treating bipolar disorder patients. The general principles of cognitive therapy were
modified to incorporate the mood dysfunctions of this disorder. The general principles
include establishing a collaborative relationship, understanding the patient's perspective,
behavioral activation during depression or deactivation during mania, educating the
patient about the cognitive approach and shifting the patient into the questioning mode.
During the manic phase specifically, demobilization included a cost/benefit analysis,
evaluation of grandiosity through the downward arrow technique, evaluating evidence for
patient’s interpretations and offering alternative explanations to counter irrational
thoughts. Beck also developed a plan for evaluating and treating suicidal impulses.
Exploration of the causes of past and current reasons for an impulse or attempt include

making a determination of whether the prior attempt was a critical incident or the
culmination of depressive thinking. He recommended using coping cards for each
patient, individually and collaboratively developed, for the patient to carry with written
coping strategies. Addressing hopelessness, reviewing the reasons for living/dying and
cognitive rehearsal was included in treating suicidality.
The competent and compassionate treatment of bipolar illness is predicated on a
solid knowledge of the disorder. A solid knowledge of bipolar illness encompasses
familiarity with the phenomenology, the natural history of the illness, its recurrent nature,
the individual personality of a patient, and the specific symptoms which create distress
and maintain its destructive course. Management additionally includes knowledge and a
general understanding of the biological aspects of the disorder, such as pharmacological
titration protocols and expected side effects. Therapists with a scientific grasp of
psychological and biological phenomenology can be more assured of the delivery of
appropriate interventions. While advances have been made in management, a solid
understanding of the specific symptoms experienced by the patient, and how those
symptoms manifest and maintain behaviors has not been identified.
Appropriate interventions have the potential to mediate the long-term outcome of
numerous pathological processes. However, many patients may receive ineffective or
inappropriate treatment for several reasons, allowing emotional scars to accumulate and
irrational thoughts to germinate. The following examples of research are presented to
illuminate this point.
Joyce (1984) reviewed the self reports and conducted personal interviews of 200
hospitalized patients at the Sunnyside Hospital in Chrischurch, New Zealand. From

this work, he found that "the median age for first affective syndrome was 23 years
(26 years for first hospitalization), and the most common age of onset was 15-19 years."
(p.145). He added that 20% to40% of adults reported that their onset of symptoms
was during childhood. Citing Kraepelin's work in 1921 as a foundation for his findings,
Joyce reiterated that Kraepelin found the commonest age of onset to be between 15 and
20 years of age.
Lish, Dime-Meenan, Whybrow, Price & Hirschfeld (1994) conducted the first
large-scale self-survey of members of the National Depressive and Manic-Depressive
Association (NDMDA). These researchers used a survey questionnaire to interpret
their data and reported that a majority of respondents experienced their first symptoms
during childhood or adolescence. In their view, individuals do not receive prompt or
effective treatment for many reasons. Either the individuals fails to seek care, or
professionals make inaccurate diagnoses, or there is a lack of long-term follow up
care. An empirically supported identification of symptom clusters and their severity may
promote more accurate diagnoses and treatment interventions.
Evans (2000) reiterated the findings of Lish, et al., and stated that a diagnosis of
bipolar disorder may go undetected or undiagnosed for many years, with patients
reporting a mean latency of illness and initiation of treatment to be a minimum of five
years. In his view, the reasons for the discrepancy between age of onset and first
treatment is that bipolar disorder is not recognized as such by the individuals,
families or their health care providers. Evans postulates that the primary basis for this is
the way in which symptoms overlap with other disorders. For example, substance abuse
or alcoholism is frequently comorbid. Bipolar disorder can be confused with

secondary mania to several other conditions.
Bolton and Gunderson (1996) also reported that a differential diagnosis of bipolar
disorder can be confounded by comorbid disorders masking the underlying difficulties
experienced by the individual. Their case illustration describes a patient with volatile
moods and impulsivity. The patient was treated for borderline personality disorder rather
than bipolar disorder because the two having similar presentations.
Post and Weiss (1995) postulate that bipolar disorder can be differentiated from
borderline personality disorder by more intractable and extreme mood swings over time.
They also propose that a lack of expedient and appropriate care can lead to a more
virulent form of the disorder.
Bipolar illness can affect every aspect of social functioning, including the
additional impact of low self-esteem and self-efficacy. The unique viewpoint of an
individual, or the subjective interpretation of events, is not necessarily a linear and
connected process. With individuals who have bipolar disorder, developing an accurate
perspective of the world is fraught with and tempered by periods of euphoric
interpretation, and then episodes of switching to a viewpoint clouded by depression.
The goals of a bipolar patient are equally disrupted, with cognitive load increasing during
psychotic periods. The euthymic phase, which can occur between episodes of
depression and mania, may be the only period when judgment and insight are realistic.
Executing a rational and consistent plan of action may be an impossibility with repeated
bipolar mood swings. A good mood can cause one to be less accurate in appraising the
environment and forming judgments. Bipolar disorder exacerbates that lack of accuracy
to an extreme form.

Expectations of acceptable behavior circumscribe how one should behave within
the social mores of a society. The nature of support of family members, friends and
professionals in any lifelong, chronic illness can be critical. Bipolar disorder drives
behaviors which are typically unacceptable, and without intervention can become self
destructive. During depression, feelings of guilt over behaviors committed during mania
can be a great source of disparagement. Self-enhancing coping strategies which are more
readily available to someone not suffering with a severe mood disorder may become
obscure. Cognitive dissonance over one's inconsistent attitudes, beliefs and behaviors is
magnified when those variables change due to uncontrollable mood swings. Many
outcome studies find marked impairment with pharmacological intervention, despite
overt symptomatic improvement. Data support what experienced clinicians already
know: combined psychotherapy and pharmacological strategies are more effective than
medication alone, especially in improving function.
The consideration of a psychiatric illness with classical and normative
characteristics such as bipolar disorder is currently limited to therapeutic advances in
treatment of the acute and chronic behavioral manifestations of the disorder. The
possibility that identifiable, common and salient symptoms exist which provide
opportunities for appropriate and effective interventions, to minimize the destructive
nature of the course of this illness, appears to be a valid focus of consideration. The
identification of a cluster of those symptoms could alert mental health professionals to
employ treatments specifically designed to address the more encompassing needs of an
individual with bipolar disorder.
Wells, Kataoka & Asarnow (2001) have noted that approximately one in five

young people in the United States experience a depressive episode by eighteen years of
age. However, less than half of those affected received any mental health services. This
is due to a variety of factors such as a lack of identification by pediatricians, brief
medical visits which preclude comprehensive evaluation, and limited or lacking medical
coverage. The knowledge that this disorder can be considered a major risk factor for
suicide underscores how effective treatments may ultimately be precluded, if the illness
is not treated appropriately in a timely fashion.
This study can potentially provide mental health professionals with a powerful
tool; the ability to identify significant symptoms of bipolar disorder. This knowledge
could be used to intervene appropriately and effectively with a truly vulnerable
population, which is frequently misdiagnosed and therefore underserved. Individuals
experiencing only the internal symptoms of bipolar disorder may be dealing with severe
mental illness, ineffective treatment, the loneliness and despair of being misdiagnosed,
and contraindicated medications. The focus of this investigation was to identify
common, salient and significant symptoms of bipolar disorder. The ultimate purpose of
this study was to advance effective treatment strategies that provide these individuals
with the support they so desperately need to deal with such a significant mental illness.
The fundamental principle forwarded in this statement is that a simplistic
approach to treating severe behavioral manifestations of bipolar disorder in isolation may
actually create iatrogenic illness. Currently, individuals who display behavioral
dyscontrol, hyperactivity, or any number of distressing problems may receive palliative
interventions designed to treat the specific or blatant symptom in isolation. For example,
adolescents who appear to be dysmorphic may be prescribed antidepressants, which may

in turn precipitate an initial manic event.
This paper proposes a paradigm shift in the treatment of behavioral or emotional
symptoms. Just as a high fever may signify a much more serious illness, dysphoria or
hyperactivity may be only one symptom in a cluster of signifying bipolar disorder.
Stimulant medication may suffice to eliminate the behavioral manifestations of
hyperactivity. However, if hyperactivity is one symptom within a specific cluster, which
points towards pathological processes leading to severe mental illness, is that treatment a
judicious or prudent one? To treat any significant and chronic symptom in a preemptory
fashion suggests that these symptoms are not part of a complex human being, with an
interconnected and evolving physiology.
Consistent with the objective of identifying salient and empirically based
symptom clusters is a consideration promulgated by Beutler & Malik (2003). State of the
art differential diagnostic decisions are predicated on what many clinicians recognize as
vaguely defined or poorly related presentations in the DSM-IV-TR (2000) text revision.
The need for more accuracy and specificity in describing bipolar disorder, based on
empirical data, is congruent with this current trend.
The DSM-IV-TR (2000) taxonomy classifies psychopathology within a disease or
illness model. This model affords a heuristic shortcut for identifying disorders and points
toward a medical model of treatments. This macro approach to disorders can divert
attention away from distressing symptoms or the needs of the individual who experiences
them. In addition, this model tends to limit the defining criteria and treatment of
disorders to their behavioral or overt manifestations. This approach may be insufficient
in accurately evaluating a disorder, leading to treatments which do not fully address the

needs of the individual.
The DSM-IV-TR (2000) text revision states that persistent symptoms of the
mood disturbance of bipolar disorder include an inflated self-esteem or grandiosity, being
more talkative than usual, distractibility, or excessive involvement in pleasurable
activities that have a high potential for painful consequences, to a significant degree. The
authors do not explain what their criteria are for defining such descriptors, so that
subjective clinical judgment is necessary to make a determination on each level every
time with every patient. Data regarding the extent to which the diagnostic symptoms
outlined correspond to individuals with bipolar disorder is also not available.
Although the focus of this research proposal is to identify the specific symptoms
of bipolar disorder, a comparison group of unipolar participants may provide information
regarding a differential cluster of symptoms. It is therefore proposed that any
information gleaned during this project, which offers insight, and can contribute to the
enhanced treatment of individuals with mental illness will be garnished and presented.
Research Questions
This investigation proposed to answer several questions, which are currently
undefined, or have not been fully addressed in the literature. The following information
was pursued:
1.

What are the distinguishing and common symptom clusters of bipolar disorder

which, when identified, could alert professionals in the field to view those symptoms
within a larger perspective?
2.

What are the specifically distinguishing symptoms of individuals who have

bipolar disorder or unipolar depression, and how are they expressed differently from

individuals who do not have severe affective disorders?
Markers
Geller & Luby (1997) have found that prepubertal bipolar disorder does manifest
with several problematic symptoms. As they state, it is a “nonepisodic, chronic, rapiddisorder (ADHD) and CD or have features of ADHD and/or CD as initial
manifestations." p.1169. Geller & Luby also add that "across the life span, grandiose
delusions must be judged by failure to follow the laws of logic and by a firm belief ".
Popper, C. (1996) has suggested viewing the degree and quality of
characteristics presented as a way to determine a differential diagnosis between ADHD
and bipolar disorder in children. The characteristics he notes for bipolar disorder are:(a)
intentional destructiveness; (b) a longer duration of angry outbursts lasting up to several
hours; (c) tantrums triggered by parental limit setting; (d) irritability in the morning on
arousal; (e) motivational problems and; (f) misbehavior with intent rather than by
accident.
Biederman, Wozniak, Kiely, Ablon, Faraone, Mick and Kraus (1995) found one
premorbid symptom of bipolar disorder in childhood to be hyperactivity. This disorder
does appear to correlate somewhat with later onset of bipolar disorder, as well as
hyperactivity continuing to be a pathological, comorbid symptom of mania, as well.
Geller & Luby (1997) also found conduct disorder to be an initial manifestation of
prepubertal onset bipolar disorder, perhaps relating to poor judgment and grandiosity.
The classic symptoms which differentiate bipolar disorder should bear the
scrutiny pertaining to issues of face validity. Manic symptomatology can include
dysphoric mood, psychomotor pressure, psychosis, increased hedonic function, and

irritable aggression. Additional symptoms cited in the DSM-IV-TR (2000) text revision
can include inflated self-esteem, grandiosity, a decreased involvement in goal directed
activities or psychomotor agitation. Also listed is an excessive involvement in
pleasurable activities with a high potential for painful consequences.
Egeland, Hostettere, Pauls & Sussex (2000) conducted a retrospective study
searching for early predictors of bipolar illness among an Amish population. They
reviewed and systematically coded a sample of 58 adult medical records of patients from
the social history at first admission and subsequently diagnosed with bipolar disorder to
identify prodromal features and possible patterns of symptoms. Their method was to use
three raters who independently abstracted information for all possible prodromal or
antecedent features from social histories at first admission. Using a semi structured
"Log" designed to note the following: (1) any mention of mood: (2) any "objective"
symptoms (e.g. appetite, sleep, behavior); and (3) any "subjective" symptoms (e.g.
cognition, feelings)." (p.1245). Family members were asked to report the developmental
stage and/or age at which entries were coded. The analyses were then subjected to SPSS
(Version 9.0, 1998). The symptoms/behaviors these researchers found with the highest
frequency were "depressed mood...increased energy...decreased energy/tired
...anger/dyscontrol and/or quick temper and argumentative, ...and irritable mood....
commonly reported included bold/intrusive behaviors, excessive behaviors, and conduct
problems;...decreased sleep and cried;... and overly sensitive." (p.1245). Findings
revealed that symptoms of episodic mood changes, as well as energy plus anger
dyscontrol, appeared nine to twelve years before the onset of documented bipolar
disorder.

Egeland et al (2000) also found that the highest frequency of symptoms or
behaviors in their study were depressed mood, increased energy, decreased energy, anger
dyscontrol/quick temper and argumentativeness, and irritable mood. Less common
symptoms included bold/intrusive behaviors, excessive behaviors, conduct problems,
decreased sleep and being overly sensitive. These researchers report that most symptoms
were episodic.

Hypotheses
Bipolar disorder is currently diagnosed according to the expression of symptoms
delineated in the DSM-IV-TR (2000) text revision. Currently, definitions of this illness
have not included the degree of the common, distinguishing, and empirically based
symptoms of individuals with bipolar disorder. This paper generally proposed
that individuals with bipolar disorder have overt symptoms as well as those experienced
internally, which specifically correlate with bipolar disorder, and can be identified by an
examination of data as endorsed and reported by those individuals. Those symptoms may
include both the obvious depression and mania, but also symptoms found by Egeland et
al (2000), as well as Hirschfield et al (2000). It was hypothesized that several symptoms
would become empirically supported markers of this disorder. It was generally
hypothesized that individuals with bipolar disorder would endorse symptoms and
symptom clusters that unite and distinguish bipolar disorder.
Hypothesis #1
The Hostility dimension (Derogatis, 1994), which measures qualities such as rage,
aggression, irritability, and resentment, will be greater for individuals with BPD than

either UD or control participants.
Hypothesis #2
The Paranoid Ideation dimension measures projective thought, hostility, suspiciousness,
grandiosity, centrality, fear of loss of autonomy, and delusions as reported by Swanson,
Bohnert, & Smith (1970). This measure will be greater for BPD than for UD or control
participants.
Hypotheses #3
The Psychoticism dimension (Derogatis, 1994) measures constructs such as isolation,
schizoid thinking, hallucinations and thought control. This measure will be greater for
BPD than for UD or control participants.
Hypothesis #4
The Interpersonal Sensitivity dimension (Derogatis, 1994) includes statements reflecting
inadequacy, inferiority, self-deprecation, self-doubt, acute self-consciousness and marked
discomfort in interpersonal interactions with negative expectations of those interactions.
This measure will be equally greater for BPD and UD, and lower for control participants.
Hypothesis #5
The Global Severity Index, which is reported to be the best single indicator of the degree
of a disorder, will be equally greater for BPD and UD, and lower for control participants.
Hypothesis #6
The Anxiety dimension (Derogatis, 1994) measures signs such as nervousness, tension,
trembling, panic attacks and dread. This measure will be greatest for UD, less so for
BPD, and even lower for control participants.
Hypothesis #7

The Depression (Derogatis, 1997) dimension represents symptoms of dysphoria,
withdrawal, lack of motivation or interest, loss of energy, hopelessness, suicidality and
somatic correlates. This measure with be equally greater for BPD and UD, and lower for
control participants.

CHAPTER 2
Methods
Participants
The data used to conduct this study was garnished from 30 individuals with a
formal diagnosis of bipolar disorder, who had joined a support group as outpatients.
A comparison group of 30 participants with unipolar depression was proposed, matching
for age, sex, and educational level. Those participants were garnished in a likewise
fashion from an outpatient support group. A matched group of 30 nonpatient adults was
selected from a pool. Administration of the identical measures with standardized
instructions was given for the purpose of providing a comparison of the rates, patterns
and severity of symptomatology of the three groups.
Recruitment of these participants occurred through a direct request for
participation at support group meetings for individuals with bipolar or unipolar disorders.
Recruitment of nonpatient adults was made through appeals to the PCOM graduate
student body for participation in a research study, with no financial reimbursement.
From those respondents and their willingness to participate, a matched sample was
gleaned of individuals who met the criteria outlined.
Prior to data collection, standard informed consent was distributed for information
purposes only, without a request for identifying signatures, to protect the anonymity of
the participants.
Overview of the Research Design
An attempt was made to methodically investigate the symptoms of bipolar
disorder precisely. This included their common occurrence and the degree to which these

symptoms typically occur in a systematic way which allows for harvesting pertinent data
for analysis.
Criteria for inclusion in study
The independent variables consisted of the group of individuals with bipolar
disorder, those with unipolar disorder, and the nonpatient adult matched sample. All
participants with BPD and UD would be asked to provide a formal diagnosis as
determined by psychiatric evaluation. A formal psychiatric diagnosis would be a
criterion of participation of individuals with bipolar or unipolar disorder in this
investigation.
Corroboration of a formal diagnosis would be ascertained by the standardized
administration of two self-report inventories. All participants would be asked to
complete the Beck Depression Inventory - II (Beck, 1996) and the Mood Disorders
Questionnaire (Hirschfield et al, 2000). The expectation was that individuals with
unipolar depression would endorse items generally associated with major depression, but
not mania or hypomania. Individuals with bipolar disorder were expected to endorse
both affective states.

Measures
The Beck Depression Inventory - II (Beck, 1996) is a self-report designed to
assess depression, using 21 questions in a Likert scale format. This inventory has been
designed to more closely correlate with criteria listed in the DSM - IV-TR (2000) text
revision. This inventory has proven to have clinical sensitivity and reliability in
measuring depression for ages 13 through 80, and was useful in screening for individuals

with unipolar depression in this research design.
Hirschfield et al (2000) have developed and investigated a questionnaire for the
purpose of screening individuals with bipolar I and II in the community. The Mood
Disorder Questionnaire poses three general questions and asks for the degree that the
symptoms caused a problem. Specifically focusing on a cluster of symptoms typically
associated with mania, the following symptoms were surveyed: (1) feeling hyper; (2)
irritable; (3) more self-confident; (4) requiring much less sleep; (5) much more talkative;
(6) easily distracted and trouble concentrating; (7) much more energy; (8) much more
active; (9) much more social; (10) much more interested in sex; (11) excessive, foolish or
risky behavior; (12) and spending money which created trouble. In trials, this
questionnaire has yielded good results regarding both sensitivity and specificity. The
authors have therefore concluded that it is a useful screening instrument for bipolar I and
II. As a measure of mania or hypomania, the Mood Disorders Questionnaire would also
be administered to all participants to corroborate a diagnosis of Bipolar Disorder.
The symptoms listed in the SCL-90-R were considered to be dependent variables.
This dissertation proposed to use a subject selection design, exploring the relationship
between reported behavioral and affective symptoms and the three groups of participants.
These symptoms are included because of their face validity.
Use of a normed symptom checklist , the Symptom Checklist -90-Revised, was
proposed to discover symptoms which may prove to be of significance to this study.
The use of this checklist was based upon its comprehensive nature as a broad-spectrum
instrument that contains 90 endorsable items, which screen for psychopathological
processes and distress.

An item analysis was planned, along with an analysis of the nine “Primary
Symptom Dimensions". The nine Primary Symptom Dimensions are: (1) somatization;
(2) obsessive-compulsive; (3) interpersonal sensitivity; (4) depression; (5) anxiety; (6)
hostility; (7) phobic anxiety; (8) paranoid ideation; and (9) psychoticism. The three
"Global Indices" include: a “Global Severity Index”, a “Positive Symptom Total” and a
“Positive Symptom Distress Index". These offer perspectives regarding the level of the
individual’s distress. The “Global Severity Index" is reported to be the best single
indicator of the severity of a disorder measured by the SCL-90-R (Derogatis).
Internal consistency reliability, or the homogeniety of items selected to represent
each symptom construct of the SCL-90-R has been reported to be satisfactory . Specific
coefficients ranged from a low of .77 for the Psychoticism Index to .90 for the
Depression Index (Derogatis, Rickels, & Rock, 1976). Test-retest reliability has also
been reported with a one-week interval for a sample of heterogeneous psychiatric
outpatients by Derogatis, et al., to be .80 to .90. Test-retest reliability was further
supported with a ten-week interval to be .68 for the Somatization to .83 for the Paranoid
Ideation Index by Horowitz.
Construct validity, or the degree to which there is a relationship between the
items of the SCL-90-R and the purported theoretical constructs which they represent, has
been reported by Derogatis & Cleary (1977). Examining the internal structure of the
SCL-90-R, the researchers reported that the empirical-theoretical match was confirmed.
Factorial invariance, or the degree of constancy when using a measure with various
groups of individuals comprised according to characteristics such as sex or age, has also
been reported. Acceptable levels of invariance for all nine-symptom dimensions were

found across the parameter of gender.
Convergent-discriminant validity or the correlation of one measure of interest
with another measure, has been reported by Derogatis, Rickels & Rock (1976). The
SCL-90-R has been found to be highly correlated with the Minnesota Multiphasic
Personality Inventory constructs with one exception. The Obsessive-Compulsive Index
had no directly comparable scale on the MMPI.
The SCL-90-R was chosen as a vehicle for a preliminary study of the
identification of symptoms of bipolar disorder for several reasons. Based on the
validity and reliability estimates presented, as well as the broad based nature of the items
presented in the SCL-90-R, it appears as though most characteristics typically associated
with bipolar disorder will be represented in this self-report measure

Procedures
The use of a standardized, structured scale, The Symptom Checklist-90-R
(Derogatis, 1994) was proposed to collect information from all participants. The choice
of this checklist was made because it is an extensively tested inventory which screens for
a broad array of symptoms and allows an individual to report the intensity of those
symptoms experienced.
The specific procedures planned were to collect data about significant symptoms
or clusters of symptoms those individuals with bipolar disorder experience. One
investigator, a Psy.D. Candidate, certified as a School Psychologist in Pennsylvania and
New Jersey, was responsible for collecting generic information, distributing the Informed
Consent, administration of the SCL-90-R, the Beck Depression Inventory - II, the Mood

Disorders Questionnaire, hand scoring the checklist, and entering the data for analysis.
Endorsement of those symptoms was collected using the three measures, with
standardized instructions as outlined in the respective manuals. A control group of
unipolars were treated in an identical fashion simultaneously, as well as a randomized
matched sample from a pool of nonpatient adults. All groups additionally completed a
questionnaire of generic information.
Measures were reviewed immediately after completion by participants, to
determine if items were endorsed which indicated potential suicidality. Should any
participants have positively endorsed key items in the BDI or SCL-90-R, item numbers
two and 15 respectively, which reflected that potential, they would have been asked to
privately meet with the researcher to evaluate the possible risk. A decision would then
have been made of appropriate steps needed to protect the participant from harm. The
least intrusive process would have taken place that insured the safety of every participant.
To protect the confidentiality of every participant, one cover sheet of identifying
information was distributed along with the three protocols. That cover sheet was then
torn and discarded, after reviewing the respective protocols and insuring that they were
completely endorsed, and that risk suicidality was not present.
Results
Plan for Statistical Analysis
A statistical analysis of the results was planned to determine if a relationship
exists between each reported symptom and its degree of severity with bipolar disorder. A
multivariate analysis of variance (MANOVA) was planned as a procedure for testing the
equality of mean vectors of the three groups. The groups were compared on the multiple

response variables simultaneously. F-tests were used in this case to assess the seven
hypotheses under consideration to determine the significant differences among these
groups. The F-tests did provide significant differences, and a multiple comparison
analysis was conducted to determine where the specific differences occur.

Plan for Statistical Analysis
The results may be a beginning step in attempting to conceptualize a collection of
distinguishing symptoms and their severity, which contribute in identifying bipolar
disorder with specificity. It was anticipated that the preliminary data would demonstrate
an effect size which is significant and substantiates the seven hypotheses outlined.
This preliminary study could have revealed that the characteristics are not a
manifestation of disorder in particular, or merely anecdotal but not significant. In either
case, this study hoped to add information to the scientific literature, which was not
available to date.

CHAPTER 3

Results
All variables were coded and processed by use of the computer program version
of SPSS Version 10.0, the Statistical Package for the Social Sciences. A Chi Square was
employed as the test of significance between groups. A multivariate analysis of variance
(MANOVA) with group membership serving as the levels of the independent variable
and factor scores of symptom dimensions serving as dependent variables was calculated.
This section includes the following: demographic and clinical variables of the
participants in this study, a statistical analysis of each dimension examined, and the
results of each hypothesis.
Demographic Characteristics
A total of 90 individuals participated in the study: 30 individuals were diagnosed
with bipolar disorder, 30 individuals with unipolar depression and 30 nonpatient adults.
The mean age of the group was 40.72 years (SD = 13.556), ranging in age from 18 to 68.
The majority of the sample was female (72%) and the primary language of all
participants was English. Approximately one third of the participants were married
(35.6%), another third were single (33.3%), and the remainder was divorced/separated
(31.1%). Many participants had a college degree (30%), most had a high school
degree/GED (41.1%), several had a graduate degree (18.9%), some had technical training
(7.8%), and two participants had an associate degree (2.2%). The majority of
participants were employed (61%).The remainder were students (15%), unemployed
(8%), disabled (5%) or retired (2%).

A Chi-Square was completed to confirm that the control and clinical groups were
equivalent with regard to the variable of gender (

2

= 4.127, df =2, p =.127). Results

indicated that there were no differences between the groups with regard to age (F (2, 8) =
53.378, p = .753).

Age of Onset
Clinical groups were compared regarding the age of onset for the primary
diagnosis. The reported mean age of onset of bipolar disorder was 18.51. The reported
mean age of onset of unipolar disorder was 22.56.

Table 1 presents demographic

information including the variables with categorical responses of individuals with bipolar
disorder (BD), unipolar disorder (UD), and nonpatient adults for comparison.

Table 1
Demographic Variables of Participants
________________________________________________________________________
Bipolar Disorder

Unipolar Disorder

Nonpatient Adults

Variable Category
Frequency Percent
Frequency Percent Frequency Percent
________________________________________________________________________
Gender
Male

8

26.6

10

33.3

6

20

Female

22

73.3

20

66.6

24

80

Single

14

46.6

9

30

7

23.3

Married

6

20

9

30

17

56.7

Separated/Divorced

10

33.4

12

40

6

19.7

High School/GED

14

46.7

13

43.3

10

33.3

Technical School

2

6.7

4

13.3

1

3

A.A.

2

6.7

0

0

0

0

B.A.

11

37

8

26.6

8

26.6

M.A.

1

3

5

16.7

7

23.3

Unemployed

2

6.7

6

20

0

0

Student

2

6.7

5

16.7

7

23.3

Disabled

4

13.3

1

3

0

0

Employed

21

70

18

60

22

73.3

Retired

1

3

0

0

1

3

Marital status

Education

Employment

Confirmatory Measures of Diagnoses
Beck Depression Inventory - II
Data were analyzed to determine if a significant difference existed between
groups based on the Beck Depression Inventory-II. A significant difference was found,
F(2,78)=33.17, p=.001.
Results of the Beck Depression Inventory - II (Beck, 1996) indicated that the
group with bipolar disorder yielded a total score M = 23.93, SD = 14.096. The group
with unipolar disorder yielded a total score M = 24.14, SD = 11.819. The group of
nonpatient adults yielded a total score M = 3.27, SD = 3.424, as shown in Table 2.
A post hoc analysis was completed to determine which of the between group
differences of the two clinical groups and control group were significant. Results of the
Games-Howell Analysis indicated that both clinical groups did not differ and were
significantly higher than the control group as shown in Table 3.

Table 2

Means and Standard Deviations of Scores of the Beck Depression Inventory
________________________________________________________________________
Bipolar Disorder

Unipolar Disorder

Nonpatient Adults

Dimension
M
SD
M
SD
M
SD
________________________________________________________________________
Beck Depression
23.93 14.096
24.14 11.819
3.27 3.424
Inventory
________________________________________________________________________
Note. Participants with bipolar disorder (BPD), participants with unipolar disorder (UD).

Results of the Games-Howell Analysis of the Beck Depression Inventory
revealed that the group with bipolar disorder did not differ from the group with unipolar
disorder. This analysis also revealed that both groups of individuals with bipolar or
unipolar disorder endorsed symptoms of depression to a significantly greater degree than
nonpatient adults.

Table 3
Games-Howell Post Hoc Analysis Test of the Beck Depression Inventory
______________________________________________________________________
1 = bpd
2 = ud
Mean
3 = controls
Difference
Significance
______________________________________________________________________
Dependent Variable

1

2

-.22

.998

3
20.66*
.000
____________________________________________________
Beck Depression

2

Inventory

3
20.87*
.000
____________________________________________________
3

1

.22

.99

1

-20.66*

.000

2

-20.87*

.000

____________________________________________________________________________________
Note. Participants with bipolar disorder (BPD), participants with unipolar disorder (UD).

The Mood Disorders Questionnaire
Data were analyzed to determine if a significant difference existed between
groups based on the Mood Disorders Questionnaire. A significant difference was found,
F(2,78)=58.676, p=.001.
Results of the The Mood Disorders Questionnaire (Hirschfield, 2000) indicated
that the group with bipolar disorder endorsed items which yielded a total score M = 9.93,
SD = 2.960. The group with unipolar disorder endorsed items which yielded a total score
M = 3.89, SD = 2.936. The group of non patient adults endorsed items which yielded a
total score M = 2.08, SD = 2.365 as shown in Table 4.

A post hoc analysis was completed to determine which of the between group
differences impacted Mood Disorder Questionnaire results. The Scheffe Post Hoc Test
was used because there were no significant differences in the variances of the groups on
this measure. Results of the Scheffe Post Hoc Test indicated that the bipolar group was
significantly higher than both the unipolar and control group and no significant difference
was found between the unipolar group and the control group as shown in Table 5.

Table 4
Means and Standard Deviations of Total Items Endorsed on the Mood Disorders
Questionnaire
________________________________________________________________________
Bipolar Disorder

Unipolar Disorder

Nonpatient Adults

Dimension
M
SD
M
SD
M
SD
________________________________________________________________________
Mood Disorders
Questionnaire
9.93 2.960
3.89
2.936
2.08 2.365
________________________________________________________________________
n = 30 for each group.

Table 5
Scheffe Post Hoc Analysis Test of the Mood Disorders Questionnaire
________________________________________________________________________
1 = bpd
Dependent Variable 2 = ud
Mean
3 = controls
Difference Significance
________________________________________________________________________
1

2

6.03*

.000

Mood Disorders

3
7.85*
.000
______________________________________________________

Questionnaire

2

1

-6.03*

.000

3
1.82
.062
______________________________________________________
3

1

-7.85*

.000

2

-1.82*

.062

______________________________________________________________________________________

Note. Participants with bipolar disorder (BPD), participants with unipolar disorder (UD).

Results of the Scheffe Post Hoc Analysis of the Mood Disorders Questionnaire
revealed that the group with bipolar disorder did significantly differ from the group with
unipolar disorder and from the group of nonpatient adults.

Symptom Checklist 90-R Dimensions.
Derogatis (1977) presented a concept of caseness, as defined with regard to the
SCL-90-R. A dimension T score of 63 corresponds to the 90th percentile of the normative
population which can serve as a positive diagnostic indicator. A T score analysis of the
symptom dimensions was conducted. On each dimension, it was found that participants
with bipolar disorder generally endorsed items that were reflected in T scores nearly two
standard deviations above the normed mean. In comparison, participants with unipolar
disorder endorsed items that were reflected in T scores generally more than one standard
deviation above the normed mean. Finally, nonpatient adults were found to endorse
items within the mean. These results suggested that individuals with bipolar disorder
generally experience greater levels of pathognomic symptoms than those experienced by
individuals with unipolar disorder.
A multivariate analysis of variance (MANOVA) with group membership serving
as the levels of the independent variable and factor scores of symptom dimensions
serving as dependent variables was calculated. An overall Wilks' Lambda (Wilks =
F=13.37, df=14,162, p<.000) revealed a significant difference across groups on the levels
of the independent variable. The Games-Howell Post Hoc Test yielded multiple
supportive results. All three levels of the independent variable were found to affect the
degree of symptomatology and symptom cluster aggregation.
Subsequently, post hoc analyses of variance (ANOVA's) were conducted on each
of the dependent variables with group membership as the independent variable. F-tests
were used to assess the seven hypotheses to determine the significant differences among

the three groups of participants. A multiple comparison analysis was then conducted.
Significant results were discovered for all dimensions as shown in Table 7.

Table 6
Means and Standard Deviations of T score Comparisons of SCL-90-R Dimensions
________________________________________________________________________
Bipolar Disorder

Unipolar Disorder

Nonpatient Adults

Dimension
M
SD
M
SD
M
SD
________________________________________________________________________
Hostility

69.13

9.519

63.53 10.405

46.50 5.776

Paranoid

69.43

9.088

63.53 9.457

48.77 7.281

Psychoticism

73.10

8.168

68.53 8.858

46.70 5.873

Interpersonal Sensitivity

72.50

7.123

67.97 10.424

48.33 7.331

Global Severity Index

73.03

6.557

69.13 8.959

46.47 6.862

Depression

71.90

7.279

70.60 9.511

46.67 6.504

Anxiety
70.83 8.363
66.20 10.196
44.00 6.592
________________________________________________________________________

Table 7
ANOVA of SCL-90R Dimensions
_______________________________________________________________________
Dimension
df
F
p
_______________________________________________________________________
Hostility

2,78

53.856

90

.001

Paranoid

2,78

45.323

90

.001

Psychoticism

2,78

99.725

90

.001

Interpersonal Sensitivity

2,78

69.675

90

.001

Global Severity Index

2,78

108.732

90

.001

Depression

2,78

97.813

90

.001

Anxiety
2,78
85.188
90
.00
________________________________________________________________________

Analyses of Hypotheses
Hypothesis # 1.
The Hostility dimension of the SCL-90-R (Derogatis, 1994) measures qualities
such as rage, aggression, irritability, and resentment. It was predicted that hostility would
be greater for individuals with bipolar disorder and lower for individuals with unipolar
disorder or control participants. Support for the first hypothesis indicated a trend. Both
clinical groups met the criterion of clinically significant levels on the Hostility
dimension. Hostility was significantly greater for the clinical groups and lower for the
control group.
The Hostility dimension revealed the following scores for each level of the
independent variable. Results of the Hostility dimension analysis demonstrated that the
group with bipolar disorder endorsed items which were reflected in T scores nearly two
standard deviations above the normed mean (M = 69.13, SD = 9.519). These scores for
bipolar subjects indicated a positive clinically significant level as measured by the
Hostility dimension. The bipolar subjects do experience clinical levels of symptoms such
as rage, aggression, irritability, and resentment to a significantly greater degree than
nonpatient adults.
The group with unipolar disorder endorsed items on the Hostility dimension
which were reflected in T scores more than one standard deviation above the normed
mean (M = 63.53, SD = 10.405). These scores for unipolar subjects indicated a positive
clinically significant level as measured by the Hostility dimension. These scores
indicated that the unipolar subjects also experience clinical levels of symptoms such as

rage, aggression, irritability, and resentment to a significantly greater degree than
nonpatient adults.
The group of nonpatient adults endorsed items on the Hostility dimension which
were reflected in T scores within the mean range (M = 46.50, SD = 5.776). These scores
for control subjects indicated that a positive relationship on the Hostility dimension was
not found. These scores indicated that the nonpatient adult subjects do not experience
clinical levels of symptoms such as rage, aggression, irritability, and resentment to a
significantly greater degree when compared with population norms.
The Games-Howell Post Hoc Test was used to determine where the specific
differences occurred between groups on the Hostility Dimension because the variances of
the three groups were unequal, due to the nature of the clinical and nonpatient groups
which were compared.
The Hostility dimension revealed that participants with bipolar disorder did not
score significantly higher than participants with unipolar (M Difference = 5.60, SE =
2.575, p<.084) but were significantly higher than nonpatient adults (M Difference =
22.63, SE = 2.033, p<.000). Participants with unipolar disorder did score significantly
higher than nonpatient adults (M Difference, 17.03, SE = 2.173, p<.000), see Table 8.

Table 8
Games-Howell Post Hoc Tests of Hostility Dimension
________________________________________________________________________
1 = bpd
Dependent Variable 2 = ud
Mean
3 = controls
Difference
SE
Significance
________________________________________________________________________
1

2

5.60

2.575

.084

3
22.63*
2.033
.000
______________________________________________________
Hostility
2

1

-5.60

2.575

.084

Dimension
3
17.03*
2.173
.000
______________________________________________________
3

1

-22.63*

2.033

.000

2
-17.03*
2.173
.000
_______________________________________________________________________
Note. Participants with bipolar disorder (BPD), participants with unipolar disorder (UD).
* The mean difference is significant at the .05 level.

Hypothesis # 2.
The Paranoid Ideation dimension of the SCL-90-R measures projective thought,
hostility, suspiciousness, grandiosity, centrality, fear of loss of autonomy, and delusions
as reported by Swanson, Bohnert, & Smith (1970). It was predicted that this score would
be greater for bipolar disorder than for unipolar disorder or control participants. The
second hypothesis was supported. While both clinical groups met the criterion of
clinically significant levels on the Paranoid dimension, the Paranoid dimension was
significantly greater for the bipolar group and lower for the unipolar and control groups
(M Difference = 20.6, SE= 2.395, p<.044).
The Paranoid dimension revealed the following scores for each level of the
independent variable. Results of the analysis demonstrated that the group with bipolar
disorder endorsed items on the SCL-90-R which were reflected in T scores near two
standard deviations above the mean. These scores for bipolar subjects (M = 69.43, SD =
9.088) indicated a positive clinically significant level as measured by the Paranoid
dimension over nonpatient adults. The interpretation of these scores revealed that the
bipolar subjects do experience clinical levels of symptoms such as projective thought,
hostility, suspiciousness, grandiosity, centrality, fear of loss of autonomy, and delusions
to a significantly greater degree than nonpatient adults.
The group with unipolar disorder endorsed items on the Paranoid dimension
which were reflected in T scores more than one standard deviation above the mean (M =
63.53, SD = 9.457). These scores for unipolar subjects indicated a positive clinically
significant level as measured by the Paranoid dimension. These scores suggested that the
unipolar subjects also experience clinical levels of symptoms such as projective thought,

hostility, suspiciousness, grandiosity, centrality, fear of loss of autonomy, and delusions
to a significantly greater degree than nonpatient adults.
The group of nonpatient adults endorsed items on the Paranoid dimension which
were reflected in T scores within the mean range (M = 48.77, SD = 7.281). These scores
for nonpatient adults indicated that a positive clinically significant level as measured by
the Paranoid dimension was not found. These scores suggested that the nonpatient adult
subjects do not experience symptoms of projective thought, hostility, suspiciousness,
grandiosity, centrality, fear of loss of autonomy, and delusions to a significantly greater
degree when compared with population norms..
The Games-Howell Post Hoc Test was used to determine where the specific
differences occurred between groups on the Paranoid dimension. The post hoc analysis
was conducted because the variances of the three groups were unequal, due to the nature
of the clinical and nonpatient groups which were compared.
The Games-Howell Post Hoc Test comparisons demonstrated the following on the
Paranoid dimension: bipolar disorder did score significantly greater than unipolar
disorder participants (M Difference = 5.90, SE= 2.395, p<.044); and were significantly
higher than nonpatient adults (M Difference = 20.67, SE = 2.126, p<.000). The GamesHowell Post Hoc Test comparisons also revealed that participants with unipolar disorder
did score significantly higher than nonpatient adults (M Difference = 14.77, SE = 2.179,
p<.000), as shown in Table 9.

Table 9
Games-Howell Post Hoc Tests of Paranoid Dimension
______________________________________________________________________
1 = bpd
Dependent Variable 2 = ud
Mean
3 = controls
Difference
SE
Significance
______________________________________________________________________
1

2

5.90*

2.395

.044

3
20.67*
2.126
.000
____________________________________________________
Paranoid

2

Dimension

3
14.77*
2.179
.000
____________________________________________________
3

1

-5.90*

2.395

.044

1

-20.67*

2.126

.000

2

-14.77*

2.179

.000

___________________________________________________________________________________
Note. Participants with bipolar disorder (BPD), participants with unipolar disorder (UD).

Hypothesis #3.
The Psychoticism dimension (Derogatis, 1994) measures constructs such as
isolation, schizoid thinking, hallucinations and thought control. It was predicted that this
measure would be greater for bipolar disorder than for unipolar disorder or control
participants. Support for the third hypothesis approached significance. A Games-Howell
Post Hoc Test analysis indicated that both clinical groups met the criterion of clinically
significant levels on the Psychoticism dimension when compared to nonpatient adults.
The bipolar and unipolar groups did not differ. The Psychoticism dimension was
significantly lower for the control group.
The Psychoticism dimension revealed the following scores for each level of the
independent variable. Results of the Psychoticism dimension analysis demonstrated that
the group with bipolar disorder endorsed items on the SCL-90-R which were reflected in
T scores more than two standard deviations above the mean (M = 73.10, SD = 8.168).
These scores for bipolar subjects indicated a positive clinically significant level on the
Psychoticism dimension. The interpretation of these scores suggested that the bipolar
subjects do experience clinical levels of constructs such as isolation, schizoid thinking,
hallucinations and thought control to a significantly greater degree than nonpatient adults.
The group with unipolar disorder endorsed items on the Psychoticism dimension
which were reflected in T scores more than one standard deviation above the mean (M =
68.53, SD = 8.858). These scores for unipolar subjects indicated a positive clinically
significant level as measured by the Psychoticism dimension. These scores suggested
that the unipolar subjects also experience clinical levels of constructs such as isolation,

schizoid thinking, hallucinations and thought control to a significantly greater degree than
nonpatient adults.
The group of nonpatient adults endorsed items on the Psychoticism dimension
which were reflected in T scores within the mean range (M = 46.70, SD = 5.873). These
scores for nonpatient adult subjects indicated that a clinically significant level on the
Psychoticism dimension was not found. These scores suggested that the nonpatient adult
subjects do not experience clinical levels of constructs such as isolation, schizoid
thinking, hallucinations and thought control to a significantly greater degree when
compared with population norms.
The Games-Howell Post Hoc Test was used to determine where the specific
differences occurred between groups on the Psychoticism dimension because the
variances of the three groups were unequal, due to the nature of the clinical and
nonpatient groups which were compared.
The Psychoticism dimension revealed that participants with bipolar disorder did
not score significantly higher than participants with unipolar disorder (M Difference=
4.57, SE = 2.20, p<.104) but were significantly higher than nonpatient adults (M
Difference = 26.40, SE = 1.83 p<.000). Participants with unipolar disorder did score
significantly higher than nonpatient adults (M Difference= 21.83, SE = 1.940, p<.000), as
shown in Table 10.

Table 10
Games-Howell Post Hoc Tests of the Psychoticism Dimension
_______________________________________________________________________
1 = bpd
Dependent Variable 2 = ud
Mean
3 = controls
Difference
SE
Significance
______________________________________________________________________
1

Psychoticism
Dimension

2

4.57

2.200

.104

3
26.40
1.837
.000
____________________________________________________
2
1
-4.57
2.200
.104
3
21.83
1.940
.000
___________________________________________________
3

1

-26.40

1.837

.000

2

-21.83

1.940

.000

__________________________________________________________________________________
Note. Participants with bipolar disorder (BPD), participants with unipolar disorder (UD).

Hypothesis #4.
The Interpersonal Sensitivity dimension (Derogatis, 1994) includes statements
reflecting inadequacy, inferiority, self-deprecation, self-doubt, acute self-consciousness
and marked discomfort in interpersonal interactions with negative expectations of those
interactions. It was predicted that this measure would not differ for both bipolar disorder
and unipolar disorder, and that Interpersonal Sensitivity would differ and be lower for
control participants. The Games-Howell Post Hoc Test supported the fourth hypothesis
that both clinical groups were significantly greater and differed from the control group on
Interpersonal Sensitivity dimension.
The Interpersonal Sensitivity dimension offered the following scores for each
level of the independent variable. Results of the Interpersonal Sensitivity dimension
analysis demonstrated that the group with bipolar disorder endorsed items on the SCL90-R which were reflected in T scores more than two standard deviations above the mean
(M = 72.50, SD = 7.123). These scores for bipolar subjects indicated a positive clinically
significant level on the Interpersonal Sensitivity dimension. These scores indicated that
the bipolar subjects do experience clinical levels of feelings of inadequacy, inferiority,
self-deprecation, self-doubt, acute self-consciousness and marked discomfort in
interpersonal interactions with negative expectations of those interactions, to a
significantly greater degree than nonpatient adults.
The group with unipolar disorder endorsed items on the Interpersonal Sensitivity
dimension which were reflected in T scores more than one standard deviation above the
mean (M = 67.97, SD = 10.424). These scores for unipolar subjects indicated that there is
a clinically significant level on the Interpersonal Sensitivity dimension. These scores

indicated that unipolar subjects also experience clinical levels of feelings of inadequacy,
inferiority, self-deprecation, self-doubt, acute self-consciousness and marked discomfort
in interpersonal interactions with negative expectations of those interactions, to a
significantly greater degree than nonpatient adults.
The group of nonpatient adults endorsed items on the Interpersonal Sensitivity
dimension which were reflected in T scores within the mean range (M = 48.33, SD =
7.331). These scores for nonpatient adult subjects indicated that a positive clinically
significant level on the Global Severity Index was not found. These scores suggested that
the nonpatient adult subjects do not experience clinical levels of feelings of inadequacy,
inferiority, self-deprecation, self-doubt, acute self-consciousness and marked discomfort
in interpersonal interactions with negative expectations of those interactions, to a
significantly greater degree when compared with population norms.
The Games-Howell Post Hoc Test was used to determine where the specific
differences occurred between groups on the Interpersonal Sensitivity dimension because
the variances of the three groups were unequal, due to the nature of the clinical and
nonpatient groups which were compared.
The Interpersonal Sensitivity dimension revealed that participants with bipolar
disorder did not score significantly higher than unipolar disorder participants (M
Difference = 4.53, SE = 2.305, p<.131) but were significantly higher than nonpatient
adults (M Difference = 24.17, SE = 1.866. p<.000). Participants with unipolar disorder
did score significantly higher than nonpatient adults (M Difference = 19.63, SE = 2.327,
p<.000) as shown in Table 11.

Table 11
Games-Howell Post Hoc Tests of Interpersonal Sensitivity Dimension
_______________________________________________________________________
1 = bpd
Dependent Variable 2 = ud
Mean
3 = controls
Difference
SE
Significance
______________________________________________________________________
1
Interpersonal

2

4.53

2.305

.131

3
24.17
1.866
.001
____________________________________________________

Sensitivity
2

1

4.53

2.305

.131

3
19.63
2.327
.001
____________________________________________________
3

1

-24.17

1.866

.001

2
-19.63
2.327
.001
_____________________________________________________________________
Note. Participants with bipolar disorder (BPD), participants with unipolar disorder (UD).

Hypothesis #5.
The Global Severity Index (Derogatis, 1994) represents clinical levels of the
intensity of perceived distress, or the depth of a disorder. It was predicted that this
measure would not differ for both bipolar disorder and unipolar disorder, and that the
Global Severity Index would differ from and be lower for control participants. The fifth
hypothesis was supported. The bipolar group and the unipolar group did not differ on the
Global Severity Index however both the bipolar and unipolar groups were significantly
greater than the control group.
The Global Severity Index revealed the following scores for each level of the
independent variable. Results of the Global Severity Index analysis demonstrated that the
group with bipolar disorder endorsed items on the SCL-90-R which were reflected in T
scores more than two standard deviations above the mean (M = 73.03, SD = 6.557).
These scores for bipolar subjects indicated a positive clinically significant level as
measured by the Global Severity Index. These scores indicated that the bipolar subjects
do experience clinical levels of the intensity of perceived distress, or the depth of
disorder, to a significantly greater degree than nonpatient adults.
The group with unipolar disorder endorsed items on the Global Severity Index
which were reflected in T scores more than one standard deviation above the mean
(M = 63.19, SD = 8.959). These scores for unipolar subjects indicated a positive clinically
significant level as measured by the Global Severity Index. The interpretation of these
scores suggested that unipolar subjects do experience the intensity of perceived distress,
or the depth of disorder, to a significantly greater degree than nonpatient adults.

The group of nonpatient adults endorsed items on the Global Severity Index
which were reflected in T scores which were within the mean range (M = 46.47,
SD = 6.862). These scores for nonpatient adult subjects indicated that a positive
clinically significant level as measured by the Global Severity Index was not found.
These scores also indicated that nonpatient adult subjects do not experience the intensity
of perceived distress, or the depth of disorder, to a significantly greater degree when
compared with population norms.
The Games-Howell Post Hoc Test was used to determine where the specific
differences occurred between groups on the Global Severity Index. The post hoc analysis
was conducted because the variances of the three groups were unequal, due to the nature
of the clinical and nonpatient groups which were compared.
The Global Severity Index revealed that participants with bipolar disorder did not
score significantly higher than unipolar disorder participants (M Difference = 3.90, SE =
2.027, p<.142) but were significantly higher than nonpatient adults (M Difference
=26.57, SE = 1.733, p<.000). Participants with unipolar disorder did score significantly
higher than nonpatient adults (M Difference = 22.67, SE = 2.026, p<.000), see Table 11.

Table 11
Games-Howell Post Hoc Tests of Global Severity Index
_______________________________________________________________________
1 = bpd
Dependent Variable 2 = ud
Mean
3 = controls
Difference
SE
Significance
_______________________________________________________________________
1

2

3.90

2.027

.142

3
26.57
1.733
.000
_____________________________________________________
Global Severity
Index

2

1

-3.90

2.027

.142

3
22.67
2.026
.000
_____________________________________________________
3

1

-26.57

1.733

.000

2
-22.67
2.060
.000
______________________________________________________________________
Note. Participants with bipolar disorder (BPD), participants with unipolar disorder (UD).

Hypothesis #6.
The Anxiety dimension (Derogatis, 1994) measures signs such as nervousness,
tension, trembling, panic attacks and dread. It was predicted that the Anxiety dimension
would be greatest for unipolar disorder, less so for bipolar disorder, and even lower for
control participants. The sixth hypothesis was not supported. Bipolar and unipolar
groups did not differ on the Anxiety dimension; however both groups differed from and
were significantly greater than the control group.
The Anxiety Dimension revealed the following scores for each level of the
independent variable. Results of the Anxiety Dimension analysis demonstrated that the
group with bipolar disorder endorsed items on the SCL-90-R which were reflected in T
scores more than two standard deviations above the mean (M = 73.83, SD = 8.363).
These scores for bipolar subjects indicated a positive clinically significant level as
measured by the Anxiety dimension. The interpretation of these scores indicated that the
bipolar subjects experience clinical levels of anxiety such as nervousness, tension,
trembling, panic attacks and dread, to a significantly greater degree than nonpatient
adults.
The group with unipolar disorder endorsed items on the Anxiety dimension which
were reflected in T scores more than one standard deviation above the mean
(M = 66.20, SD = 10.196). These scores for unipolar subjects indicated a positive
clinically significant level as measured by the Anxiety dimension. These scores indicated
that unipolar subjects experience clinical levels of anxiety with symptoms such as
nervousness, tension, trembling, panic attacks and dread, to a significantly greater degree
than nonpatient adults.

The group of nonpatient adults endorsed items on the Anxiety dimension which
were reflected in T scores within the mean range (M = 44.00, SD = 6.592). These scores
for nonpatient adult subjects indicated that a positive clinically significant level as
measured by the Anxiety dimension was not found. These scores indicated that
nonpatient adult subjects do not experience clinical levels of signs such as nervousness,
tension, trembling, panic attacks and dread to a significantly greater degree when
compared with population norms.
The Games-Howell Post Hoc Test was used to determine where the specific
differences occurred between groups on the Anxiety dimension. The post hoc analysis
was conducted because the variances of the three groups were unequal, due to the nature
of the clinical and nonpatient groups which were compared.
The Anxiety dimension revealed that participants with bipolar disorder did not
score significantly higher than unipolar disorder participants (M Difference = 4.63, SE =
2.408, p<.141) but were significantly higher than nonpatient adults (M Difference =
26.83, SE = 1.944, p<.000). Participants with unipolar disorder did score significantly
higher than nonpatient adults (M Difference = 22.20, SE = 2.217, p<.000), see Table 12.

Table 12

Games-Howell Post Hoc Tests of Anxiety Dimension
_______________________________________________________________________
1 = bpd
2 = ud
Mean
3 = controls
Difference
SE
Significance
______________________________________________________________________
Dependent Variable

1

2

4.63

2.408

.141

3
26.83
1.944
.001
____________________________________________________
Anxiety

2

Dimension

3
22.20
2.217
.001
____________________________________________________
3

1

1

-4.63

-26.83

2.408

1.944

.141

.001

2
-22.20
2.217
.001
______________________________________________________________________
Note. Participants with bipolar disorder (BPD), participants with unipolar disorder (UD).

Hypothesis #7.

The Depression (Derogatis, 1994) dimension represents symptoms of dysphoria,
withdrawal, lack of motivation or interest, loss of energy, hopelessness, suicidality and
somatic correlates. It was predicted that this measure would not differ for both bipolar
disorder and unipolar disorder, and that the Depression dimension would differ and be
lower for control participants. The Games-Howell Post Hoc analysis provided statistical
support for the seventh hypothesis. The bipolar and unipolar group did not differ on the
Depression dimension; however both groups were significantly greater and differed from
the control group.
The Depression dimension revealed the following scores for each level of the
independent variable. Results of the Depression Dimension analysis demonstrated that
the group with bipolar disorder endorsed items on the SCL-90-R which were reflected in
T scores more than two standard deviations above the mean (M = 71.90, SD = 7.279).
These scores for bipolar subjects indicated a positive clinically significant level as
measured by the Depression dimension. These scores indicated that the bipolar subjects
do experience clinical levels of symptoms of dysphoria, withdrawal, lack of motivation or
interest, loss of energy, hopelessness, suicidality and somatic correlates, to a significantly
greater degree than nonpatient adults.
The group with unipolar disorder endorsed items on the Depression dimension
which were reflected in T scores more than two standard deviations above the mean
(M = 70.60, SD = 9.511). These scores for unipolar subjects indicated a positive clinically
significant level as measured by the Depression dimension. These scores indicated that
unipolar subjects do experience clinical levels of symptoms of dysphoria, withdrawal,

lack of motivation or interest, loss of energy, hopelessness, suicidality and somatic
correlates, to a significantly greater degree than nonpatient adults.
The group of nonpatient adults endorsed items on the Depression dimension
which were reflected in T scores within the mean range (M = 46.67, SD = 6.504). These
scores for nonpatient adult subjects indicated a positive clinically significant level as
measured by the Depression dimension was not found. These scores indicated that the
nonpatient adult subjects do not experience clinical levels of symptoms of dysphoria,
withdrawal, lack of motivation or interest, loss of energy, hopelessness, suicidality and
somatic correlates to a significantly greater degree when compared with population
norms.
The Games-Howell Post Hoc Test was used to determine where the specific
differences occurred between groups on the Depression dimension. The post hoc analysis
was conducted because the variances of the three groups were unequal, due to the nature
of the clinical and nonpatient groups which were compared.
The Depression dimension revealed that participants with bipolar disorder did not
score significantly higher than unipolar disorder participants (M Difference = 1.30, SE =
2.187, p<.824) but were significantly higher than nonpatient adults (M Difference =
25.23, SE = 1.782, p<.001). Participants with unipolar disorder did score significantly
higher than nonpatient adults (M Difference = 23.93, SE = 2.104, p<.000), see Table 13.

Table 13
Games-Howell Post Hoc Tests of Depression Dimension
_______________________________________________________________________
1 = bpd
Dependent Variable 2 = ud
Mean
3 = controls
Difference
SE
Significance
______________________________________________________________________
1

2

1.30

2.187

.824

3
25.23
1.782
.000
____________________________________________________
Depression

2

Dimension

3
23.93
2.104
.000
___________________________________________________
3

1

1

-1.30

-25.23

2.187

1.782

.824

.000

2
-23.93
2.104
.000
_____________________________________________________________________
Note. Participants with bipolar disorder (BPD), participants with unipolar disorder (UD).

CHAPTER 4
Discussion

The focus of this investigation was to identify common, salient and significant
symptoms of bipolar disorder. As Goodwin & Jamison (1990) note, "Surprisingly little
has been done to describe quantitatively the clinical features of bipolar depression per
se." (p.42).

Bipolar disorder is currently diagnosed according to the expression of symptoms

delineated in the DSM-IV-TR (2000) text revision. State of the art differential diagnostic
decisions are predicated on what many clinicians recognize as vaguely defined or poorly
related presentations in the DSM-IV-TR (2000) text revision. Belmaker (2004) wrote the
following regarding current diagnostic information about bipolar disorder:

"Surprisingly, studies have not identified a clear personality trait specific to
patients with bipolar manic-depressive illness. Intuition may suggest that patients
are labile, unstable, or perhaps seekers of novelty even when they are not manic
or depressed. However, there is little evidence of specific personality
characteristics." pg. 476.

The present study attempted to empirically identify symptoms to help define a
more accurate clinical description of bipolar disorder. This study was designed to
incorporate the results of current research into the preexisting pool of knowledge. An
analysis of the current results indicated that the hypotheses were largely supported. A

greater number of participants in this study could have established symptoms with more
certainty. The following discussion presents findings and their implications.

Interpretation of Research Findings
The DSM-IV-TR (2000) includes a statement that psychotic disorders "may share
a number of presenting symptoms (e.g., grandiose and persecutory delusions, irritability,
agitation, and catatonic symptoms)" (p.387). Persecutory delusions describe thoughts or
beliefs that contain the two central elements of harm occurring, and that others have the
intention to cause harm. This research has found that the participants with bipolar
disorder, who were not actively psychotic, maintained what can be described as a
paranoid set. This response set is illustrated by the number of participants who endorsed
the descriptors "quite a bit" or "extremely" in the protocol of the SCL-90-R with regard to
"Feeling that you are watched or talked about by others" or "Feelings that people will
take advantage of you if you let them." (Derogatis, 1994, p. 32). The results of this
research found that individuals with bipolar disorder significantly endorse global self
statements of paranoid ideation when compared with individuals with unipolar disorder
or nonpatient adults.

Analysis of the data indicated that individuals with bipolar disorder endorsed
items on the dimension of Hostility indicating a trend when compared with individuals
having unipolar depression. This response set is illustrated by the large number of
participants who endorsed the descriptors "quite a bit" or "extremely" in the protocol of
the SCL-90-R with regard to the self statement of "Getting into frequent arguments, or
temper outburst that you could not control"(Derogatis, 1994, p. 32). Consistent with the

hypothesis that hostility is a symptom of bipolar and unipolar disorder is the work of
Michaelis, Goldberg, Davis, Singer, et al. (2004). These researchers found that an
association between lifetime suicide attempts and overall hostility were significant among
individuals with bipolar disorder. They reported that
Analysis of the data appeared to indicate that individuals with bipolar disorder
endorsed items on the dimension of Psychoticism indicating a trend when compared with
individuals having unipolar depression. Individuals with bipolar disorder experience
clinical levels of constructs such as isolation, schizoid thinking, hallucinations and
thought control to a significantly greater degree than nonpatient adults. This finding was
consistent with the American Psychiatric Association: Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition, Text Revision (2000), which incorporates specifiers
of diagnostic features such as psychotic features, to describe a Manic, Mixed or Major
Depressive Episode.
Individuals with bipolar disorder also endorsed items which indicated clinical
levels of symptoms when measured by the Interpersonal Sensitivity dimension. This
response set was illustrated by participants who endorsed the descriptors of "quite a bit"
or "extremely" in the protocol of the SCL-90-R with regard to "Feeling shy or uneasy
with the opposite sex" or "Feeling inferior to others." (Derogatis, 1994, p. 31). Cannon, et
al. (1977), found that impaired social functioning is also seen in the premorbid state.
Additionally, these researchers have found that poor premorbid social adjustment is one
manifestation of vulnerability to adult psychotic disorders, although more so with
schizophrenia than with bipolar disorder.
Bipolar illness can affect every aspect of social functioning, including the

additional impact of low self-esteem and self-efficacy. The unique viewpoint of an
individual, or the subjective interpretation of events, is not necessarily a linear and
connected process. With individuals who have bipolar disorder, developing an accurate
perspective of the world is fraught with and tempered by periods of euphoric
interpretation, and then episodes of switching to a viewpoint clouded by depression.
Individuals with bipolar disorder also endorsed items which indicated clinical
levels as measured by the Global Severity Index. That index includes clinical levels of
the intensity of perceived distress, or the depth of disorder. Prima facie consideration
leads to the proposition that individuals who experience a mental health disorder of this
magnitude would consider the distress of the depth of their disorder to be severe.
Individuals with bipolar disorder endorsed items which indicated clinical levels
on the Depression dimension when compared with nonpatient adults. This finding was
movingly underscored by Jamison (1995):
"Profound melancholia is a day-in, day-out, night-in, night-out, almost arterial
level of agony. It is a pitiless unrelenting pain that affords no window of hope, no
alternative to a grim and brackish existence, and no respite from the cold
undercurrents of thought and feeling that dominate the horribly restless nights of
despair' (p. 144).
Individuals with bipolar disorder also endorsed items which indicated clinical
levels on the Anxiety dimension when compared with nonpatient adults. An example of
this elevated anxiety is illustrated by participants who endorsed the descriptors "Quite a
bit" or "extremely" with regard to "Nervousness or shakiness inside" or "Suddenly scared
for no reason" (Derogatis, 1994, p. 31). Support was found for this hypothesis in the

work of McElroy et al. (2001) in assessing comorbid lifetime and current axis I disorders
in 288 patients with bipolar disorder. One conclusion drawn was that patients with
bipolar disorder often have comorbid anxiety, substance use, and, to a lesser extent,
eating disorders.

Based on this study, participants with unipolar disorder were found to endorse
items which also indicated clinical levels of symptoms on dimensions of the Symptom
Checklist -90-Revised not typically associated with unipolar disorder. Of interest is the
result found that individuals with unipolar disorder elected responses which were
significantly greater on the Hostility and Paranoia dimensions when compared with
nonpatient adults. These results are consistent with those of Pasquini et al. (2004) who
proposed that:

"In depressive disorders, there are psychopathological dimensions other than
depressed mood and anxiety that deserve greater clinical recognition and research.
Our study suggests that one of these symptom clusters includes anger, irritability,
aggressiveness, and hostility. The relevance of this dimension was not related to
concurrent pharmacological treatment. Misdiagnosis of bipolar II disorder is also
unlikely to explain our findings. Possibly, personality factors might at least partly
explain the occurrence of anger and aggressiveness in several depressed patients.
Attachment theory suggests that anger might also be conceived as part of the
protest-despair-detachment reaction to a loss, either actual or symbolic." (p.155).

Based on the outcome of these measures, a conclusion is forwarded that
individuals with bipolar disorder do endorse symptoms correlated with paranoia to a

greater degree than individuals with unipolar disorder or nonpatient adults. In addition,
symptoms correlated with the dimensions of Hostility and Psychoticism did approach
significance for the bipolar population when compared with unipolar participants.
Furthermore, several symptoms have also proven to be quite stable and endorsed to a
greater degree by participants with bipolar disorder than with nonpatient adults. Those
symptoms include hostility, psychoticism, interpersonal sensitivity, anxiety and
depression, as measured by the SCL-90-R.
This investigation proposed to answer several questions regarding the
symptomatology of bipolar disorder which had not been fully addressed in the literature.
In discussing which common symptoms of bipolar disorder could alert professionals in
the field, the symptom of paranoia was found to be significant. Despite the interventions
of diagnosis, pharmacological treatment and membership in a support group, participants
with bipolar disorder continued to experience and endorse this symptom to a clinically
significant degree. This outcome points to the strength and endurance of this symptom
experienced by individuals with bipolar disorder. Furthermore, several symptoms have
also proven to be quite stable and endorsed to a greater degree by participants with
unipolar disorder than with nonpatient adults. Those symptoms include hostility,
paranoia, psychoticism, interpersonal sensitivity, anxiety and depression as measured by
the SCL-90-R.
Together, these symptoms begin to form a cluster of focal points within bipolar
disorder. It appears as though paranoia differentiates bipolar from unipolar disorder. If
this finding is replicated or corroborated by other investigators, it could prove to be a
useful indicator of early bipolar disorder, prior to manic or hypomanic events. As

McElroy, Strakowski, West, Keck and McConville (1997) concluded, adolescents are
more likely to initially present with depression. Prior to manic or hypomanic events, it is
difficult to diagnose incipient bipolar disorder. Depression experienced as part of bipolar
disorder can include the risk of suicide to a greater degree that most other psychiatric
populations (Lam, Jones, Hayward, & Bright, 1999). Statistics indicate that between
fifteen to nineteen percent of patients with bipolar disorder commit suicide, a serious
mortality figure (Goodwin & Jamison, 1990, Simpson & Jamison, 1999). These
researchers found that the suicide attempts may occur even more frequently, with
estimates as high as fifty-six percent. A diagnostic tool used to measure symptoms such
as paranoia primarily, along with the accompanying symptoms which were found to be
present in this sample, could help to identify bipolar disorder earlier and more efficiently
and possibly reduce this mortality rate.
Collateral symptoms of anxiety, interpersonal sensitivity, depression and the
severity of the degree of symptomatology for participants with bipolar disorder appear to
form a specific cluster. As noted previously, Egeland, Hostettere, Pauls & Sussex (2000)
conducted a retrospective study searching for early predictors of bipolar illness among an
Amish population. Egeland et al (2000) found that the highest frequency of symptoms
or behaviors in their study were depressed mood, increased energy, decreased energy,
anger dyscontrol/quick temper and argumentativeness, and irritable mood. Less common
symptoms included bold/intrusive behaviors, excessive behaviors, conduct problems,
decreased sleep and being overly sensitive. In view of the findings of this study,
symptoms identified by England et al (2000) appear to correlate with the symptoms of
hostility, interpersonal sensitivity, and depression found to be endorsed by participants

with bipolar disorder.
A discussion of the symptoms endorsed by participants with unipolar disorder
appears to be a worthwhile endeavor in light of the findings of this investigation. The
same symptoms endorsed by participants with bipolar disorder were also largely
endorsed by participants with unipolar disorder. It appears as though a relationship also
exists between the independent variables of hostility, paranoia, psychoticism,
interpersonal sensitivity, global severity, depression and anxiety, and the dependent
variable of unipolar disorder. Despite the interventions of diagnosis, pharmacological
treatment and membership in a support group, participants with unipolar disorder
continued to experience and endorse these symptoms to a significantly greater degree
when compared with nonpatient adults. This outcome points to the strength and
endurance of these symptoms which are experienced by individuals with unipolar
disorder. Of interest may be the identification of the symptoms of hostility, paranoia, and
psychoticism in connection with unipolar disorder, which are generally not considered to
be associated with unipolar disorder. Theoretically, individuals with unipolar disorder
may experience these symptoms, but the symptoms may not be acknowledged,
observable or directly expressed.
The overall results of this investigation point to the similarity of responses between
participants with bipolar disorder and unipolar disorder. One possibility may be that
chronic unipolar disorder and bipolar disorder share most characteristics, with the
exception of mood swings and hypomania/mania. As opposed to being an entirely distinct
disorder, the presentation of these characteristics appears to suggest that unipolar disorder

incorporates the symptoms of bipolar disorder, without the additional symptoms of
hypomania/mania.
This sample of individuals with unipolar disorder did report that their illness was
of a prolonged and chronic nature, despite psychiatric interventions and other adjunctive
treatment modalities. This sample may represent a small percentage of individuals who
experience lifelong unipolar depression which is uninterrupted. Perhaps psychiatric
interventions allow these individuals to function in the community, but do not provide
sufficient relief to fully ameliorate unrelenting symptoms.
As stated previously, Beutler & Malik (2003) report that state of the art
differential diagnostic decisions are predicated on what many clinicians recognize as
vaguely defined or poorly related presentations in the DSM-IV-TR (2000). The need for
more accuracy and specificity in describing both bipolar disorder and unipolar disorder,
based on empirical data, is congruent with this current trend. The DSM-IV-TR (2000)
taxonomy classifies psychopathology within a disease or illness model. This model
affords a heuristic shortcut for identifying disorders and points toward a medical model
of treatment. This macro approach to disorders can divert attention away from
distressing symptoms or the emotional needs of the individual who experiences them. In
addition, this model tends to limit the defining criteria and treatment of disorders to their
behavioral or overt manifestations. This approach may be insufficient in accurately
evaluating a disorder, leading to treatments which do not fully address the needs of the
individual.
The DSM-IV-TR (2000) describes persistent symptoms of the mood disturbance
of bipolar disorder. The authors do not explain what their criteria are for defining such

descriptors, so that subjective clinical judgment is necessary to make a determination on
each level with every patient. Data regarding the extent to which the diagnostic
symptoms outlined correspond to individuals with bipolar disorder is also not available.
Based on the literature review cited earlier, a paradigm shift was proposed in the
treatment of behavioral or emotional symptoms for individuals with bipolar disorder.
Rather than treatment of a blatant symptom of bipolar disorder such as mania or rage,
other significant and chronic symptoms which are part of a complex human being, with
an interconnected and evolving physiology, warrant consideration. The treatment of
symptoms which were found to be embedded within bipolar disorder may offer a
substantial benefit to those individuals, as well as provide mental health professionals
opportunity to develop for more efficacious treatment regimens.

Implications for Clinical Practice
The general theme and purpose of this research was to identify the various core
symptoms of bipolar disorder and thereby broaden an understanding of the dynamics
involved within the individual with bipolar disorder. In the present diagnostic system,
chronic unipolar and bipolar disorders are classified on the basis of overt symptoms as
distinct psychiatric disorders: an individual either has the illness or does not. Viewing
bipolar and unipolar disorder in this way suggests that emphasis on a few defining
symptoms may be misleading. Depression, for example, occurs in many disorders and
can often be treated with medications, regardless of etiology. While some overt
symptoms may be necessary for a diagnosis, such as the hallmark mania of Bipolar I,
these overt symptoms are not sufficient in describing or treating individuals. Viewing
individuals with unipolar or bipolar disorder in a distinct categorical rather than a

dimensional way can be a reductionistic approach which does not promote a
comprehensive therapeutic model.
One interesting finding of this research study was the lack of a significant
difference between bipolar and unipolar disorder on the Hostility dimension. While it
was predicted that hostility would be greater for individuals with bipolar disorder and
lower for individuals with unipolar disorder or control participants, a significant
difference between unipolar and bipolar disorder was not found. This finding is
interpreted to mean that individuals with chronic unipolar disorder may experience the
same feelings of hostility that individuals with bipolar disorder experience and exhibit.
However, they do not necessarily acknowledge those feelings, or act upon them. These
feelings may not manifest in behaviors which define unipolar disorder, however, they
appear to exist when measured by the SCL-90-R. When mental health clinicians do not
test or filter for this or any other important symptom or maladaptive cognitive process
because of preconceived decisions regarding the generally accepted view of a mental
health disorder, a risk is taken.
Likewise, another interesting finding of this research study was the response
pattern of individuals with bipolar and unipolar disorder on the Paranoid dimension.
While both groups met the criterion of clinically significant levels on the Paranoid
dimension, the Paranoid dimension was significantly greater for the bipolar group. It
appears as though paranoid ideation as measured by the SCL-90-R is a distinguishing
characteristic among the dimensions which were tested in generating a diagnosis of
bipolar disorder. This understanding of bipolar disorder may help to form a differential
diagnosis earlier in the onset of this illness, before the manifestation of mania, when an

initial episode is limited to depression. As noted earlier, adolescents are more likely to
present with depression. If paranoia is a true expression of bipolar disorder, then this
marker could potentially be used to differentiate a major depressive episode from
incipient bipolar disorder.
Appropriate interventions have the potential to mediate the long-term outcome of
numerous pathological processes. However, many patients may receive ineffective or
inappropriate treatment for several reasons, allowing emotional scars to accumulate and
irrational thoughts to germinate. The illumination of salient and common symptoms of
bipolar disorder, which are embedded within the more pressing manifestation of mania,
hypomania or depression, offer the opportunity to address those symptoms specifically
with the intent of impacting favorably upon the individual in treatment.

Limitations of the Study
One potential limitation of the present study involved the particular characteristics
of the sample. This sample was comprised of groups of volunteers, who may by nature
differ from the general population. In addition, the clinical samples were obtained from a
support group setting. The individuals who attend support group settings may also differ
from the general population in their need or ambition to find support in such a group
setting.
This research design attempted to control for several characteristics. Participation
excluded subjects who were hospitalized during the prior year. This exclusion was used to
reduce the possibility that a participant had been recently actively psychotic. All
participants were required to have a diagnosis by a psychiatrist, and list their psychiatrist of

record, to corroborate their stated mental health disorder. All participants were 18 years or
older.
Within a group of individuals with bipolar disorder or unipolar depression,
numerous idiosyncratic characteristics may or may not have affected the individual
performance of each participant. The nature of bipolar disorder stipulates a change in mood
from one state to another on a cyclical basis. The cyclical nature of bipolar disorder can
mediate behavior, thoughts, feelings and response sets at given points in time. The
responses of the participants may in fact vary a great deal within the paradigm of mood
shifts. However, all bipolar disorder participants were considered to be stable and placed
on an appropriate regimen of medications to minimize mood disturbance.
Medications and other treatments may also affect variables which were considered.
To offset this potential, participants were chosen from a large support group. Membership
in the group provided an indication that members were functioning within the larger
community with support and attending such activities independently. Participants were in
treatment by mental health professionals who could determine if their state of mental
health was compromised by bipolar disorder or unipolar depression. Although this
particular sample may have differed from the general population, their responses are
considered to reflect their adequate cognitive ability to take tests such as the SCL-90 and
accurately report their symptomatology.
A weakness of this study involved the interpretability and generalizability of the
results. Although a large sample size is favorable in a study of this type, this was a
relatively small sample size. The relatively small sample size may have presented results
which are skewed. However, this was a preliminary study conducted with the intent to

discriminate salient symptoms from those which are relatively infrequent or do not impact
upon the participants to a significant degree.
A potential threat to the validity of this study was the reactivity of an assessment.
Participants were aware that they were being assessed and in fact endorsed a letter of
solicitation stipulating the parameters of the study. Therefore, that awareness may have
led them to respond differently than they would have under other conditions. The measures
were therefore considered to be reactive.
Potential threats also included the reactivity of an experimental arrangement. The
participants may have had a desire to please the experimenter, or participants may have
elected responses which appeared to be prosocial or considered more common among
individuals without a mental health diagnosis. To help control for this threat, introductory
remarks regarding the purpose of this study included the provision that all protocols would
be entirely confidential and anonymous and used for scientific purposes only.

Recommendations for Future Research
This investigation focused upon the symptoms contained within the SCL-90Revised measure. Future studies are needed to examine the full spectrum of significant
symptoms experienced by individuals with bipolar disorder.
The overall results of this investigation point to the similarity of responses between
participants with bipolar disorder and unipolar disorder. One possibility may be that
unipolar disorder and bipolar disorder share most characteristics, with the exception of
mood swings and hypomania/mania. A future study with a larger sample size could

delineate the specific symptoms which differentiate bipolar disorder from unipolar disorder
with greater certainty.
Further investigation is indicated to explore the relationships between unipolar
disorder and the symptoms coincidentally identified. For example, the finding in this study
of hostility, which measures qualities such as rage, aggression, irritability, and resentment,
was not significantly greater for individuals with bipolar disorder than individuals with
unipolar disorder. An investigation focused upon elucidating the nuances of unipolar
disorder and enhancing understanding of this disorder could impact favorably upon
treatment outcomes.
Several characteristics have been enumerated in the literature as descriptors of
bipolar disorder. The verity of every descriptor has not been empirically investigated.
Although they may be observable patterns of behavior, the underlying symptoms remain
unclear. The question of what psychologically pathognomic symptoms perpetuate the
cyclical nature of bipolar disorder is still unanswered.
This was a preliminary study designed to begin to establish the salient and common
symptoms of bipolar disorder. An extension of this work could help to formulate more
definitive diagnostic criteria and provide more efficacious treatment paradigms for
individuals with bipolar disorder.
Finally, much interest has been generated about bipolar disorder in children and
adolescents. As presented earlier, Geller & Luby (1997) have found that prepubertal
bipolar disorder does manifest with several problematic symptoms. An empirical
investigation of the common and salient symptoms of bipolar disorder within these lower
age groups would appear to offer greater insight regarding diagnoses and therapeutic

interventions designed to specially address those symptoms.
This study can potentially provide mental health professionals with a powerful
tool; the ability to identify significant symptoms of bipolar disorder. This knowledge
could be used to intervene appropriately and effectively with a truly vulnerable
population, which is frequently misdiagnosed and therefore underserved. Individuals
experiencing only the internal symptoms of bipolar disorder may be dealing with severe
mental illness, ineffective treatment, the loneliness and despair of being misdiagnosed
and contraindicated medications. The focus of this investigation was to identify
common, salient and significant symptoms of bipolar disorder. The ultimate purpose of
this study was to advance a focus for effective treatment strategies that provide these
individuals with the support they so desperately need to deal with such a significant
mental illness.
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Appendix A

Copy of Cover Letter
Dear Participant,
Your participation in this study is strictly confidential. The purpose of this study
is to investigate the specific symptoms of bipolar or unipolar depression. Hopefully,
this research will provide new information which is helpful in diagnosing and treating
individuals with these disorders. Your signature at the bottom will be used during this
session only for the temporary purpose of keeping track of who is completing which form
and screening for symptoms of risk or harm. During this meeting, you will be asked to
fill in three surveys and one page of general information about you. Afterward, all of
these materials will be reviewed by the investigator. If you present with risks of harm,
such as suicidal thinking, you will be asked to meet with the investigator to review and
assess those symptoms. At that time, appropriate interventions will take place to insure
your safety, such as a referral to a mental health professional.

After you hand in the

attached materials, the investigator will review the information. Upon review of all
materials, this letter will be destroyed to protect your anonymity.
I thank you for your contribution to this research project.

Please sign___________________________________________________________

Appendix B
Copy of Volunteer Letter of Agreement to Participate in Study
Dear Volunteers,
The purpose of this research project is to find the important and common
symptoms of individuals with bipolar disorder, and how this may differ from individuals
with unipolar depression or from the general population. You are being asked to be in
this research study because you have been diagnosed with Bipolar I, Bipolar II, Unipolar
Depression, or are a nonpatient adult (to compare symptoms). The title of this study is:
A PRELIMINARY STUDY OF SPECIFIC SYMPTOMS EXPERIENCED BY
INDIVIDUALS WITH BIPOLAR DISORDER
The investigators of this study are:
Barbara Golden, Psy.D. Assistant Professor ( Principal Investigator)
Philadelphia College of Osteopathic Medicine
4190 City Avenue
Philadelphia, PA 19131
Gail Reichman Mancini, M.A., M.S. (Responsible-Investigator)
Philadelphia College of Osteopathic Medicine
4190 City Avenue
Philadelphia, PA 19131
If you have any questions about this research, you can call Dr. Golden at
(215) 871-6495. If you have any questions or problems during the study, you can ask Dr.
Golden, who will be available during the entire study. If you want to know more about
Dr. Golden's background, or the rights of research subjects, you can call Dr. John
Simelaro, Chairperson, PCOM Institutional Review Board at (215) 871-6337.
You will be given a packet which contains a cover letter, one page asking for
general information about you, and three different surveys about your thoughts, feelings
or behavior. The entire time needed to complete these items should be about 30 minutes.
When you are through, the investigator will collect your materials. If there are any
questions about your information, such as forgetting to fill in information in some places,
the investigator will meet with you. If you have any questions or need any help, please
feel free to ask. If you have been psychiatrically hospitalized during the past six months,
you are intoxicated or under the influence of drugs not prescribed by your physician, or
are having severe difficulty in answering questions, you can not be in this study. If at any
time you indicate a desire to harm others or yourself, your confidentiality will not be
maintained. The investigator will follow the necessary ethical and legal procedures to
ensure your safety and the safety of others.
The benefits of participating in such a study include the opportunity to participate
in research aimed at increasing knowledge about bipolar disorder. You may not benefit
from being in this study. Other people in the future may benefit from what the
researchers learn from the study. There are no known risks or discomforts from being in
the study, and you do have the choice of not being in this study. You will not receive any
financial reimbursement for being in this study.

All information and medical records relating to your participation will be kept in a
locked file. Only the doctors, members of the Institutional Review Board, and the U.S.
Food and Drug Administration will be able to look at these records. If the results of this
study are published, no names or other identifying information will be used.
There are no known risks to participating in such a study. However, some people
may experience discomfort by participating in a research project which deals with the
potentially delicate issues of distress related to your illness. It is expected that this
discomfort will be minimal and temporary, such as evoking a sad mood. The potential
benefits of participating include being part of a beginning step in recognizing the
distinguishing symptoms and their severity, which contribute to identifying bipolar
disorder. This study hopes to add information to the scientific literature, which is not
available to date. The knowledge gained from this study may help individuals with
bipolar disorder become identified earlier and with greater accuracy. That can lead to
better and earlier treatments for individuals. You may also gain additional insight and
self knowledge. Therefore, the benefits will be long lived and cumulative by contributing
to the literature base.
If you have any questions or problems during the study, you can ask Dr. Golden,
who will be available during the entire study. You may refuse to be in this study and
may leave this study at any time.
Thank you again for your help in this study, which is very much appreciated.
Sincerely,
_____________________________
Gail Reichman Mancini, M.A., M.S.
Psy.D. Candidate

____________________
Barbara Golden, Psy.D.

Appendix C
INFORMED CONSENT FORM
TITLE OF STUDY
A PRELIMINARY STUDY OF SPECIFIC SYMPTOMS EXPERIENCED BY
INDIVIDUALS WITH BIPOLAR DISORDER
PURPOSE
The purpose of this research is to find out what specific symptoms people with bipolar
disorder experience. You are being asked to be in this research study because you have
been diagnosed with Bipolar I or Bipolar II or depression.
INVESTIGATOR(S)
Name: Barbara Golden, PhD
Department: Psychology
Address:
**
Phone: (215) 861-6442
The doctors and scientists at Philadelphia College of Osteopathic Medicine (PCOM) do
research on diseases and new treatments. The procedure you are being asked to volunteer
for is part of a research project. If you have any questions about this research, you can
call Dr. Golden at (215) 871-6495.
If you have any questions or problems during the study, you can ask Dr. Golden, who
will be available during the entire study. If you want to know more about Dr. Golden's
background, or the rights of research subjects, you can call Dr. John Simelaro,
Chairperson, PCOM Institutional Review Board at (215) 871-6337.
DESCRIPTION OF THE PROCEDURES
You will be asked to fill out the following questionnaires, which include many
different symptoms. The time needed to fill these forms out will be about 25 minutes.
Afterward, people will be randomly selected for a few minutes to discuss this project. If
you have any questions, you may ask the researchers at any time for help.
POTENTIAL BENEFITS
You may not benefit from being in this study. Other people in the future may
benefit from what the researchers learn from the study.

RISKS AND DISCOMFORTS
There are no known risks or discomforts from being in the study.
ALTERNATIVES
It is entirely your choice if you decide to participate in this study.
PAYMENT
You will not receive any payment for being in this study.
CONFIDENTIALITY
All information and medical records relating to your participation will be kept in a locked
file. Only the researchers or members of the Institutional Review Board will be able to
look at these records. If the results of this study are published, no names or other
identifying information will be used.
NEW FINDINGS
If any new information develops that may affect your willingness to stay in this study,
you will be told about it.
INJURY
If you are injured as a result of this research study, you will be provided with immediate
necessary medical care. However, you will not be reimbursed for medical care or receive
other payment. PCOM will not be responsible for any of your bills, including any routine
medical care under this program or reimbursement for any side effects that may occur as
a result of this program.
If you believe that you have suffered injury or illness in the course of this research, you
should notify John Simelaro, D.O., Chairperson, PCOM Institutional Review Board at
(215) 871-6337. A review by a committee will be arranged to determine if your injury or
illness is a result of your being in this research. You should also contact Dr. Simelaro if
you think that you have not been told enough about the risks, benefits, or other options,
or that you are being pressured to stay in this study against your wishes.
VOLUNTARY PARTICIPATION
You may refuse to be in this study
You may leave this study at any time
You also understand that if you drop out of this study, there will be no penalty or loss of
benefits to which you are entitled.

I have had adequate time to read this form and I understand its contents. I have been
given a copy for my personal records.
I agree to be in this research study.
Signature of Subject:_____________________________________________
Date: _____/_____/______

Appendix D
Copy of Confidential Information for Research Purposes Only

CONFIDENTIAL INFORMATION FOR RESEARCH PURPOSES ONLY
Dear Participant,
Please include all information that you may feel is helpful in this
research project. Thank you for your help, which is very much appreciated.
Participant # ________________________________________________
Date of Birth_________________________________________________
Age: ______________________________________________________
Ethnicity: Caucasian African-American Hispanic Other
Marital Status: Married Single
Divorced Separated
Education: GED
High School
Technical School B.A. M.A.
M.S.
Ph.D/Psy.D.
M.D. J.D.
Sex (circle one): M F
Employment:
Unemployed
Student
Employed Full Time
Part Time
Disabled
Your Diagnosis: Bipolar I
Bipolar II
Depression No Diagnosis
Initial diagnosis you were given when you began having problems and
your age at that time:____________________________________________
Your age at the beginning your symptoms/illness:_____________________
What were those initial symptoms?_________________________________
_____________________________________________________________
Year you were accurately diagnosed:_______________________________
Who accurately diagnosed you? ___________________________________
All additional diagnoses you were given before you were diagnosed
correctly, your age and by whom:__________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
All current medications:__________________________________________
_____________________________________________________________
Current mental health treatment: psychiatrist psychologist support group
Name and telephone #______________________________________
Have you been treated as an inpatient within the last year? Yes
No

